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Chapter 1
Literature review
1.1 Introduction
There has been a growth in the elderly population as well in developed as in
developing countries [Rorrey et al., 1987]. Elderly people are defined by the
WHO as people over 65 years of age. In 1994, Sweden showed the largest
proportion of over 65 years olds (15 %). Sweden was the ”oldest” nation
with a percentage of 18 % of over 65 year old people [WHO, 1995]. Life
expectancy still increases steadily in developed countries. For example, life
expectancy in Sweden increased from 78 years in 1990 to 81 years in 2009
[WHO, 2011b].
In most industrialised countries ratio between men and women is 65:100 due
to differences between life expectation of male and female. Further, this ratio
is likely to decrease in industrialised countries [WHO, 1995].
Cardiovascular diseases act as death cause number one in industrialised coun-
tries [Ali et al., 2009]. 80 % of CVDs occur in low and middle income coun-
tries. Men and women are affected almost equivalent. It is expected that
CVD will contribute to about 23,6 million deaths in 2030, thus CVD will
continue to be the worlds leading death cause [WHO, 2011a].
2CVD does not nessesarily lead to death. After an cardiovascular incident
physical disability, lifelong dependence and medications are possible conse-
quences. Thus, in prospective to the financial burden of the health system,
the social and physical burden of the patients and their relatives need to be
considered [Panico and Mattiello, 2010]. With regard to the public health
burden of CVD it is important to operate with well implemented and planned
programs of prevention [EUROCISS, 2007]. Therefore, it is essential to give
accurate dietary recommendations.
For the last five decades research payed attention to the role of dietary fat
in CVD. When until recently it was recommended to decrease the fat intake,
it is now discussed whether or not it is more beneficial to lay focus on fat
quality to lower the CVD risk. The food industry recognised the marketing
potential of health products. Thus customers sight was changing. The word
dietary fat adopted a bad image for the bodies health, while ”fat-free” or
”low-fat” equaled health. However sugars and refined carbohydrates were
the substitute for fat [Hu et al., 2001].
The European nutrition and health report 2009 collected data of dietary
intake from 25 European countries. These data were used to observe a link
at an ecological level between dietary habits and mortality from CVD of the
European population. Further it was to ascertain differences among regions
in energy providing nutrients and CVD mortality.
It was to evaluate whether a population with a high fat intake or a high
carbohydrate intake is troubled with a higher CVD mortality. Furthermore
it was to identify the role of quality of fat in mortality from CVD.
In addition, trends in time of nutrient uptake and mortality from CVD in
the various European populations should have been detected.
1.2 Cardiovascular Disease (CVD)
CVD’s are diseases of heart and blood vessels which comprise [WHO, 2011a]:
3• coronary heart disease: disease of the blood vessels supplying the heart
muscle
• cerebrovascular disease: disease of the blood vessels supplying the brain
• peripheral arterial disease: disease of blood vessels supplying the arms
and legs
• rheumatic heart disease: damage to the heart muscle and heart valves
from rheumatic fever caused by streptococcal bacteria
• congenital heart disease: malformations of heart structure existing at
birth
• deep vein thrombosis and pulmonary embolism blood clots in the leg
veins, which can dislodge and move to the heart and lungs
1.2.1 Risk factors
Blood pressure
A high blood pressure is linked directly to coronary heart diseases (CHD)
[Stamler et al., 1993]. The WHO MONICA project evaluated within 38
populations in 21 countries that systolic and diastolic blood pressures varies
between the populations [op Reimer et al., n.d.] Further, the Seven Countries
Study has demonstrated that the relative mortality increase of CHD is similar
to a given increase in blood pressure between varying populations [Menotti
et al., 1996].
4Table 1.1: Reference values for lipoproteins in blood serum [Graham et al.,
2007]
Total cholesterol < 5.0 mmol/l
LDL-cholesterol < 3.0 mmol/l
HDL-cholesterol >1.2 mmol/l
TG < 1.7 mmol/l
Blood lipids
The fat-like substance cholesterol which travels in blood is part of the cell-
membranes and precursor of bile acids and steroid hormones. It contains
lipoproteins like the low density lipoproteins (LDL), the high density lipopro-
teins (HDL) and the very low density lipoproteins (VLDL). Another lipopro-
tein of the cholesterol appears as intermediate density lipoprotein (IDL)
which exists between VLDL and HDL, therefore, is included in the LDL
measurement in clinical practice [NCEP, 2002].
Cholesterol levels are linked to the CVD risk. According to Graham
et al., 2007, LDL makes usually up 60-70 % of the total serum cholesterol
and represents the most artherogenic lipoprotein. HDL is with a content of
20-30 % inversely correlated with CHD risk. The chylomicrons are built in
the intestine and are TG rich lipoproteins, which are probably artherogenic
[NCEP, 2002].
The European society of Cardiology published guidelines for reference
values to see in Table 1.1 [Graham et al., 2007].
Plasma lipid levels are as well affected by dietary factors like saturated
fat, polyunsaturated fat, monounsaturated fat, total fat, dietary cholesterol,
dietary carbohydrates, dietary fibre, alcohol, and caloric intake as by body
weight [Shils et al., 1994].
5Diabetes
Diabetics show higher serum lipids, remarkably in triglycerides. Therefore
diabetics are exposed to a higher risk of CVD [Watsen, 2000].The San Anto-
nio Heart Study found higher parameters of CVD risk factors (Table 1.2.1).
Table 1.2: Parameter of CVD risk factors in diabetic and non-diabetic per-
sons [Haffner et al., 1990]
Diabetics Nonconverter P value
(n18) (n490)
BMI (kg/m2) 30,2 27.2 0.472
Triglycerides (mmol/l) 1.83 1.28 0.006
HDL-cholesterol (mmol/l) 1.14 1.28 0.045
Systolic blood pressure (mmHg) 116.8 108.8 0.004
Obesity
Obesity is an independent risk factor for CVD [Poirier et al., 2006]. It is
caused by positive caloric balance, unhealthy lifestyle, genetic predisposi-
tion, and environmental causes [Bays, 2011]. Further, obesity (BMI > 30
kg/m2) is a risk factor for metabolic diseases such as Typ II Diabetes Melli-
tus, high blood pressure, and dyslipidemia which indirectly rise the CVD risk
[Bays, 2009]. The WHO suggested a median BMI of 21-23 kg/m2 as most
favourable for a population <65 years to reduce the risk of chronic diseases
and obesity. A BMI of 21 kg/m2 is considered to be more advantageous for
wealthy societies with a more inactive lifestyle and a BMI of 23 kg/m2 for
developing countries [(WHO) et al., 2003].
Despite the fact that visceral fat tissue plays a major part in the de-
velopment of metabolic diseases, circulating free fatty acids coming from
subcutaneous fat tissue ( 80 % of body fat) contribute to lipotoxic effects
6on the liver. Thus, CVD risk factors like hyperglyceremia and dyslipidemia
occur [Bays and Ballantyne, 2006]
Cardiovascular and adipose cells have the same origins of steam cell,
therefore, once adipocyte formations of the stem cell preceeded, adipoge-
nesis is relevant for development of CVD [Tchoukalova et al., 2010]. Peri-
cardial and perivascular adipocytes may have direct pathogenic effects on
myocardium, coronary arteries and peripheral vessels. Disregulated local
secretion of vasoactive and inflammatory factors may be responsible for un-
favourable cardiovascular pathophysiologic effects [Higuchi et al., 2002]. Fur-
thermore, adipose tissue may directely contribute to CVD risk supported by
the strong link between pericardial adipose tissue and coronary calcification
[Liu et al., 2010].
Smoking
Tobacco use is a further independent risk factor for CVD. A cross sectional
study investigated the impact of cigarette smoking and novel risk factors
such as serum-C-reactive-protein, fibrinogen and homocystein levels. With a
significant dose-response relationship between smoking and these three novel
risk factors, it is likely that inflammation and hyperhomocysteinaemia are a
pathway of CVD development [Bazzano et al., 2003]. Tobacco use has also
been associated with traditional risk factors like serum cholesterol levels and
hypertension [Muscat et al., 1991].
Physical activity
Physical activity reduces clearly the risk of a CVD incidents. Although
mechanisms are not well understood, it is inversely correlated with blood
pressure, blood lipids, and diabetes mellitus (traditional risk factors) [Hu
et al., 2004].
Mora et al. took data from the Women’s Health Study to evaluate the
7impact of physical activity on the CVD risk. The mean follow up of 10.9
± 1.6 years of 27,055 apparently healthy women showed a linear decrease of
the CVD risk. Subjects with a physical activity lower than 200 kcal/week
presented the reference group. Observed risk reduction was 27 % (PA 200-
599 kcal/week), 31 % (600- 1499 kcal/week) and 41 % (>1500 kcal/week).
They examined the risk factors and noticed inflammatory and homeostatic
biomarkers such as high-sensitivity C-reactive-protein made the largest con-
tribution to lower the CVD risk (32.6 %) followed by blood pressure (27.1
%). The change of risk factors is to see in Table 1.2.1 [Mora et al., 2007].
Table 1.3: Classification of the amount of physical activity and CVD risk
reduction (P < 0.001) regarding risk parameters (mean (SD)) hyperten-
sion, body mass index (BMI), total cholesterol (TC), low density choles-
terol (LDL), high density cholesterol (HDL), and high sensitivity C-reactive-
protein (CRP) [Mora et al., 2007].
Physical Activ-
ity (kcal/week)
< 200 200-599 600-1499 >1500
Hypertension % 28.6 24.7 23.0 23.8
BMI, kg/m2 26.9 (5.6) 25.9 (4.9) 25.3 (4.5) 25.6 (4.7)
TC, mg/dL 210 (186-237) 209 (184-236) 207 (183-234) 207 (182-234)
LDL, mg/dL 124 (103-147) 122 (102-145) 120 (99-143) 119 (98-142)
HDL, mg/ dL 49.5 (41.3-60.2) 51.6 (43.4-61.9) 53.1 (44.1-63.1) 53.5 (44.1-64.3)
High-sensitivity
CRP, mg/L
2.5 (1.0-5.1) 1.0 (0.8-4.4) 1.8 (0.7-4.1) 1.8 (1.7-3.8)
Adults should exercise at least thirty minutes five days a week in moderate
intensity or with a powerful physical activity for twenty minutes 3 days a week
[Haskell et al., 2007]. In terms of physical activity, in Europe a North-South
was gradient observed . People in the North of Europe tend to exercise more
in there leisure time than people in the south [Elmadfa, 2009].
8Alcohol
Consumption of alcoholic beverages is a common habit in most populations
of the world. Alcohol may be protective in lower dose while excessive alcohol
consumption has harmful effects on cardiovascular health. Alcohol has un-
favourable effects on mediating pathways of the vascular endothelium, such
as oxidative stress, lipoproteins and insulin resistance. Hence immoderate
alcohol consumption has an effect on classical CVD risk factors. Therefore,
an excessive alcohol consumption is unfavourable for CVD risk [Baua et al.,
2007].
Social and environmental influences
In the past decades mortality rate of CVD dropped rapidly in western coun-
tries, whereas in some eastern countries mortality rate rose. A review of
Chow et al. of environmental and societal influences on CVD risk factors
showed dramatic falls due to risk factor changes on the population level,
combined with consequences of improved interventions and better curative
care [Chow et al., 2009].
It is hardly to believe that the rapid fall is caused only by individually
targeted interventions and differences in medical treatment. Behaviour and
choice making of human beings is determined by social norms, culture, ge-
ographics, as well as the political, economic and legal factor [Chow et al.,
2009].
There are further environmental influences such as the tobacco environ-
ment, physical activity environment, and environmental influences on diet.
When smoking is easier to determine through price regulations, public infor-
mation or policies such as smoke free workplaces or restaurants and bars, the
diet is a more complex field [Chow et al., 2009].
The price of cigarettes rose in developed countries and on the contrary de-
creased in developing countries [Guindon et al., 2002]. It is more likely to
9improve smoking habits when social norms are suitable. For instance in parts
of South Asia, the social acceptance of smoking among women is modest,
hence smoking rate is low [Rani et al., 2003]
Physical activity environment contributes to the rates of obesity [Boehmer
et al., 2006]. Further, neighbourhood safety (crime, traffic, stray dogs) and
neighbourhood attractiveness are linked to higher physical activity [Saelens
et al., 2003], as well as societal and cultural norms (car or TV ownership,
cultural influences) and policy and legislation [Chow et al., 2009].
Dietary and nutrition environment is influenced by the macro-level (leg-
islation and policy), the physical environment level (access and availability),
and the social environment level (social norms, culture) [Chow et al., 2009].
There have been associations between the local food environment (density of
fast-food-restaurants and supermarkets) and prevalence of CVD risk factors
in North America [Morland et al., 2006]. In European studies this link could
not be confirmed significantly [Cummins and Macintyre, 2006].
1.3 Dietary fat and CVD
In earlier times, it was believed that the human body could survive with
enough energy whether it came from fat or any other dietary compound.
Nowadays science is enlighten of the knowledge that unsaturated fatty acids
are an essential component in human nutrition to satisfy requirements of the
human body. An important reason for this is for instance the occurrence of
those unsaturated fatty acids in membranes [Elmadfa and Leitzmann, 2004]
Most natural dietary fats comprise 98-99 % triglycerides. Triglycerides
consist of glycerol esterified with three mainly long-chain fatty acids. The
remaining 1-2 % take in by diglycerides, monoglycerides, free fatty acids un-
saponifiable compounds, phospholipids, and sterols [Elmadfa and Leitzmann,
2004].
Most important characteristics of fatty acids are the length of the chain
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(number of C-Atoms) and the degree of saturation (number of H-Atoms).
Therefore, they have an enormous influence on physical properties and bio-
chemical functions of fatty acids [Elmadfa and Leitzmann, 2004]
Dietary fat has an impact on plasma cholesterol which is known as a
classical risk factor of CVD. The amount of energy taken in by saturated and
unsaturated fatty acids is a crucial point regarding plasma cholesterol [Shils
et al., 1994]. Further, plasma cholesterol is affected by dietary cholesterol
intake. It raises levels of total and LDL cholesterol [Hengsted et al., 1965].
However, compared to the effects of saturated fatty acids and trans fatty
acids the impact of dietary cholesterol on plasma cholesterol is relatively
small [Howell et al., 1997]. These equations as basis lead to calculations of
the effects of dietary modification on plasma cholesterol. Moreover, increase
or decrease of the CVD risk could be estimated [Shils et al., 1994].
Between fatty acids, triglycerides, cholesterol, and hyperlipidemia there
is a strong link, in the same manner as hyperlipidemia and risk of CVD
[Watsen, 2000].
1.3.1 Saturated fatty acids (SFA)
It is widely believed that a higher intake of total and saturated fat encour-
ages the development of CVD. Ecological studies are mainly the basis for
this belief.
A recent meta-analysis of Siri-Tarino et al. conducted well-designed prospec-
tive epidemiological studies to evaluate the risk of CHD stroke and total CVD
associated with a higher SFA intake. Within twenty-one studies and a follow-
up from five to twenty-three years of 347,747 subjects 11,006 developed CHD
or stroke. However, intake of saturated fat was not linked to a higher risk of
CHD, stroke or CVD. Pooled RR for the highest quantiles of saturated fat
intake was 1.07 (95 % CI: 0.96, 1.19; P = 0.22) for CHD, 0.81 (95 % CI: 0.92,
1.05; P = 0.11) for stroke and 1.00 for overall CVD(95 % CI: 0.89, 1.11; P
= 0.95) [Siri-Tarino et al., 2010].
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The association observed between SFA and CHD in the Nurses’ Health
Study was much weaker than predicted by international comparisons [Keys,
1980]. However, in metabolic studies effects on plama lipid and lipoprotein
levels were different for different SFA. SFA with 12 to 16 carbon atoms are
likely to increase total and LDL cholesterol levels. In contrast, stearic acid
(18:0) has no cholesterol-raising effect when compared with oleic acid (18:1).
Myristic acid (14:0) seems to rise cholesterol levels more than lauric acid
(12:0) or palmitic acid (16:0) [Kris-Etherton and Yu, 1997].
SFA demonstrated in early animal studies an increase of plasma choles-
terol as well as atherosclerotic lesion which are risk factors in development of
CVD [Anitschkow, 1967]. Further, in humans dietary saturated fat correlated
with the risk of CHD [Kato et al., 1973]. Randomized clinical interventions
observed protective [Ascherio et al., 1996], inverse [Gillman et al., 1997], and
no effects [Ascherio et al., 1996] when reducing SFA.
Hu et al. conducted a detailed prospective analyses of dietary fat and
CHD. They used data from the Nurses’ Health Study when 80,082 women
aged 34 to 59 years participated a 14-year follow up. Due to the large sample
size and repeated assessments of diets, this study was powerful. A weak pos-
itive association between saturated fat intake and the CHD risk was found.
5 % of energy of saturated fat in contrast to equivalent energy from CHO,
was linked with a 17 % higher risk of CHD (RR = 1.17, 95 % CI: 0.97-1.41;
P = 0.10) [Hu et al., 1997].
Even if studies are not consistent, in case of a higher intake of saturated
fat and a increase of CVD risk, it is to see in the following chapters that
a replacement and, more important, which replacement of SFA could be
beneficial to reduce risk of CVD.
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1.3.2 Monounsaturated fatty acids (MUFA)
MUFA have one double bound and a higher melting point than SFA. They
are liquid at room temperature. Representatives are palmitoleic acid (16:1
n-7) and oleic acid (OLA) (16:1 n-9). The most common MUFA in human
nutrition is OLA which contributes to 92% of total MUFA intake [Kris-
Etherton, 1990]. Olive oil and canola oil represent the most frequent used
oils [Gillingham et al., 2011].
Replacement of SFA with MUFA has impact on the total high-density
lipoprotein cholesterol (TC:HDL-C) ratio due to reduction of LDL-C levels
and sustaining HDL-C levels [Gillingham et al., 2011].
In the Nurses’ Health Study, after adjustment of fats, MUFA intake was
inversely linked with risk of CHD. Exchanging 5 % of the energy from SFA
with MUFA the estimated RR was 0.81 (95 % CI, 0.65-1.00; P = 0.05) [Hu
et al., 1997].
A Meta-analysis of Cao et al. investigated 30 controlled feeding studies
with subjects with and without diabetes to examine effects of MUFA and
CHO to bloodlipids and lipoproteins. They compared a moderate fat diet
(30.2-50 % of energy; mean MUFA intake 23.6 % of energy) with a lower fat
diet (18.3-30.2 % of Energy, mean MUFA intake 11.4 %). LDL-C decreased
in both groups similar. Moderate fat diets increased HDL-C by 2.28 mg/dl
(95 % confidence interval 1.66 to 2.90 mg/dL, P, .0001) more than low fat
diets. TAG went down in moderate fat diets (-24.79 mg/dL, P 0.00001),
whereas with low fat diets TG increased. Further, a decline of TC:HDL-C
(-0.62, P 0,0001) and non-LDL-C (-5.39 %, P 0.06) was observed in MF diet.
Conclusion of the authors was that there is a reduction of CHD risk by 6.37
% in men and 9.34 % in women (subjects with diabetes included). It may
be even more beneficial for subjects predisposed with diabetes mellitus or
metabolic syndrome to replace SFA with MUFA instead of CHO [Cao et al.,
2009].
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A landmark epidemiological trial of 11,579 men (40-59 years) in the Seven
Countries study, presented important data revealing that areas consuming a
Mediterranean diet (rich in MUFA from olive oil), even though higher in total
fat (33-40 % of energy), exhibited lower incidence of CHD mortality [Keys
and et al., 1986]. In contrast, Hegsted and Ausman observed a positive
correlation between MUFA and CHD mortality in men from 18 countries
[Hegsted and Ausman, 1988].
1.3.3 Polyunsaturated fatty acids (PUFA)
PUFA have at least two double bounds and an even higher melting point
than MUFA. Most important PUFA are linoleic acid (18:2) and α-linolenic
acid (18:3) [Gillingham et al., 2011]. A higher consumption of PUFA reduces
the risk of CHD due to a decrease of the TC:HDL-C [Lewington et al., 2007].
Further, improvement of insulin resistance is given [Summers et al., 2002]
and the reduction of systemic inflammation [Pischon et al., 2003]
As per Hu et al. due to the Nurses’ Health Study trading SFA with PUFA
it results a RR of 0.62 (95 % CI, 0.46-0.85; P = 0.002) [Hu et al., 1997].
Mozaffarian et al. observed a reduction of 19 % of CHD occurrence when
SFA are replaced with PUFA. The Meta-analysis included randomized con-
trolled trials with adults. The intervention group replaced SFA with total
PUFA of 14.9 % of total energy intake (n-3 and n-6 PUFA). The control group
ingested 5 % PUFA of total energy intake. The estimated risks had to be
quoted with standard errors. The eight included trials had restricted statisti-
cal power, nevertheless they were homogen in their study design [Mozaffarian
et al., 2010].
However, some scientists do not share the protective opinion of PUFAs
in regard to the CVD risk. There are studies which observed an increasing
risk of CVD occurrence with a high PUFA intake [Hamazaki and Okuyama,
2003]. Linoleic acid plays a key role in the inflammatory process which is the
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starting point of this hypothesis [Kris-Etherton et al., 2010].
A higher linolenic acid intake increases tissue levels of arachidonic acid
which further raises inflammatory eicosanoids. Inflammation is a main reason
to the onset and progression of CHD. Therefore CHD risk must be higher.
Additionally lowering linolenic acid leads to an increase of tissue levels of the
cardioprotective eicosapentaenoic acid (n-3 fatty acid) [Kris-Etherton et al.,
2010].
Therefore, despite the cardiovascular benefits the ADA (American Dietetic
Association) restricts intakes to <10 % due to adverse effects [Moreno and
Mitjavila, 2003]. EFSA (European Food Safety Authority) does not restrict
the intake of PUFA, instead they want to set an adequate intake, 4 % of
energy for linolenic acid and 0.5 % of energy for α-linilenic acid [EFSA,
2010].
1.3.4 Trans-fatty acids (t-FA)
In the Nurses’ Health Study a positive relationship between trans fat intake
and risk of CHD was observed. This is gernerally consistent with the prospec-
tive Health Professionals’ Follow-up Study conducted in men [Ascherio et al.,
1996].
Judd et al. investigated the impact of cis- and trans-fatty acids on blood
lipids. Trans fatty acids (t-18:1) change the apolipoprotein(a) and (b) profile
which leads to an increase of the LDL-cholesterol. The lipogenic effect of
trans-fatty acids is slightly smaller than the lipogenic effect of saturated
fatty acids [Judd et al., 1994]. Figure 1.1 gives an overview of the impact
of various fatty acids on plasma total cholesterol. Although this review of
effects of fatty acids on plasma cholesterol by Kris-Etherton and Yu derived
in 1997, it already shows the scope of consequences [Kris-Etherton and Yu,
1997].
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Figure 1.1: Effects of lauric (12:0), myristic (14:0), palmitic (16:0), elaidic
(trans 18:1), stearic (18:0), oleic (cis 28:1) and linolenic (18:2n-6) acids dif-
ferentiated to 18:1 - TC, plasma total cholesterol [Kris-Etherton and Yu,
1997]
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CHO MUFA
LDL -7.1 % -6.3 %
HDL -7.2 % 4.3 %
TG ↑ ↓
Table 1.4: Change in metabolic risk factors replacing SF with CHO or MUFA
[Berglund et al., 2007]
1.4 Carbohydrates and CVD
Studies evaluated the change in cholesterol levels in response to a relatively
high total fat diet (33-50% of energy) rich in MUFA, compared to low fat
diets (18-32% of energy) with a big fraction of carbohydrates [Kris-Etherton
and Yu, 1997]. An increase of 6-22% in HDL-cholesterol and a decrease of
2-24% in plasma triglycerides was reported in favour of fat rich diets. In
both diets, LDL-cholesterol decreased [Berry et al., 1992].
Berglund et al. conducted a 3 period 7-week randomized crossover study
with fifty-two men and thirty-three women. An average american diet with
36% fat of energy intake was modified. Of those 36%, 7% had been replaced
with CHO or MUFA. The change in LDL, HDL and TG is to see in Table 1.4.
LDL-cholesterol had a higher decrease with a CHO-diet. Further with a
CHO-diet TG rose, when with a MUFA rich diet TG decreased. Further, with
a MUFA rich diet HDL-cholesterol increased. All changes of the metabolic
risk factors were significantly different to the average american diet. Further,
changes in HDL and TG with the CHO-diet were significantly different to
changes evoked by the MUFA-diet.
Chapter 2
Material and Methods
2.1 Trends in time
Data of mortality for 25 European countries was given by the WHO database
on May 5th 2011 (http://data.euro.who.int/hfadb/). Diseases are labeled by
the International Classification of diseases (ICD10). Data for the supply of
the items, like energy, fat, carbohydrates and sugar and sweeteners provided
from Food Balance Sheets (FBS) collected by the FAO (Food and Agriculture
Organisation) database, downloaded on May 12th 2011(http://faostat.fao.org/).
FBS are assembled by the FAO and provide data on food supply at the
population level. The information is estimated on the basis of the annual
food production, imports and exports, changes in stocks, agricultural and
industrial uses within a country, as well as losses during storage and trans-
portation. FBS allow comparisons of current and developing structure of
dietary patterns at national or regional level [FAO, 2008].
Further, the 25 countries were split into four regions, due to their dietary
habits and similarities in order to receive a better picture about the trend in
time. These four regions are shown in Table 2.1.
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North Central East West South
Denmark Austria Belgium Cyprus
Finland Germany Ireland Italy
Lithuania Poland United Kingdom Spain
Sweden Slovenia France Greece
Estonia Czech Republic Netherlands Portugal
Latvia Hungary Luxembourg
Norway Romania
Table 2.1: Division of the 25 european countries
FAO database provides supply data from 1961 till 2007, however, WHO
database covers only the time form 1970 to 2007 with its mortality data
[Elmadfa, 2009].
For some countries, data were not available for all 40 years. In the case of
mortality, Cyprus collected data since 2004. Estonia, Lithuania, Latvia and
Slovenia started arising mortality data in the eighties and Germany in 1991.
For macronutrients, supply data are available since 1961 except for the Czech
Republic, Estonia, Latvia, Lithuania and Slovenia which contributed in the
nineties. Further, data of Belgium and Luxembourg were summed until the
year 2000.
Data was imported into Stata 10.0 and analysed in this statistical soft-
ware.
2.1.1 Energy
FAO FBS data provide data on energy supply as kcal/capita/day and kg/capita/day
which allegorise the food supply quantity. Here data in kcal/capita/day were
used. Energy supply was calculated by the FAO out of the grand total food
supply.
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2.1.2 Fat
Fat consumption was separated in the trend by animal fats, vegetable oils,
and oil crops. The FAOStat Database gave values in gram/capita/day for
all three parts. Total fat supply was calculated by the FAO out of the grand
total. Data of vegetable oils comprise rape and mustard seed oil, sunflower
seed oil, cottonseed oil, linseed oil, hempseed oil, sesame seed oil, copra and
coconut oil, palm kernel oil, palm oil, soybean oil, olive oil and maize oil.
Data of animal fats comprise butter, ghee, fish liver oil, other animal fats
and whale oil [FAO, 2008].
2.1.3 Carbohydrates
The FAO database did not include information about a carbohydrate supply.
Therefore, the protein supply quantity (gram/capita/day) of the grand total
was multiplied by 4 to receive the protein supply in kcal. Fat supply quantity
(gram/capita/day) was multiplied by 9.3. After subtraction of the fat and
protein supply in kcal from the energy supply, the carbohydrate supply in
kcal/capita/day results. To get carbohydrate supply in gram/capita/day
numbers were divided by 4.
2.1.4 Sugar and Sweeteners
Supply of sugar and sweeteners is specified in kilogram/capita/year. Thus, it
was divided by 365 multiplied by 1000 to compute the supply in gram/capita/day
and
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2.1.5 Mortality
To give an expression about the burden of CVD in an economic level, mor-
tality seemed to be the most reliable parameter [EUROCISS, 2007]. Data
about mortality from CVD was downloaded on 5th May 2011 and updated by
the WHO in June 2010. Mortality was stated in SDR (standardised death
rate) per 100,000 inhabitants for the population till 65 years and further
subclassified in:
• death from diseases of the circulatory system (ICD 10 codes: I00-99;
all cardiovascular diseases)
• death from cerebrovascular diseases (ICD 10 codes: I20-25)
• death from ischemic heart diseases (ICD 10 codes: I60-69)
• all deaths.
”SDR are age-standardized mortality rates, which are weighted average
of the age-specific mortality rates per 100,000 persons, where the weights
are the proportions of persons in the corresponding age groups of the WHO
standard population.” [WHO, 2008]. The standard population is based on
the average world population structure from the year 2000 to 2025. The
United Nations Population Division assesses this every two years for each
country (age and sex). Death rates of a country are multiplied with the
factor of worlds average, hence, SDR results [WHO, 2008].
2.2 Ecological Correlation
Data for nutrient intake of adults (< 65 years) and other risk factors were
taken from the European Health and Nutrition Report 2009. Objectives were
energy (MJ), total carbohydrates (% of Energy), sucrose (% of Energy), fat
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(% of Energy), saturated fatty acids (% of Energy), monounsatruated fatty
acids (% of Energy), polyunsaturated acids (% of Energy), and cholesterol
(mg).
Further risk factors included in the European Health and Nutrition Re-
port 2009 were mean body mass index (BMI, kg/m2), mean alcohol con-
sumption (g/d/capita), smoking behaviour (percentage of current smokers
in the population) and physical activity level (% of population which never
does sports or exercises). With exception of the physical inactivity, all data
was available for male and female.
Age group for BMI was 19-64 years. BMI data was self reported as well
as measured. If both was given, measured data was used for calculation of
spearman’s rho. Age group of alcohol consumption was mainly 19-64 years
with exception of Germany (15-80 years), France (19-74 years) and Italy,
Portugal, and Spain which included all ages. Current smokers were aged
45-64 years.
For mortality the same data source as for the trend evaluation (SDR per
100,000 inhabitants) was used. Data was downloaded from the WHO health
for all database (5th May 2011). Each objective was correlated with mortal-
ity from circulatory diseases, ischemic diseases, cerebrovascular diseases and
overall death rate. It was operated with mortality data from the same year
the survey or the study was conducted. If there was no data available, data
of the following or previous year was used.
To evaluate the extent to which the dietary survey-derived data and mor-
tality correlate, Spearman coefficients between nutrient consumption and
modifiable risk factors (BMI, alcohol consumption, smoking behaviour and
PAL) and mortality was estimated. Statistical software was Stata 10.0.
After evaluating data with scatter plots a new division was made. Due
to higher mortality rates of Eastern European Countries (Czech Republic,
Estonia, Hungary, Latvia, Lithuania Poland, Romania, Slovenia) they were
split from Western European Countries (Austria, Belgium, Denmark, Fin-
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land, France, Germany, Greece, Hungary, Ireland, Italy, Norway, Portugal,
Spain, Sweden, The Netherlands, United Kingdom)
In addition spearman’s rho was estimated between all objectives and the
different mortality rates, for eastern and western european countries.
Chapter 3
Results
3.1 Time Trends in food supply and mortal-
ity from CVD
Present study was conducted to describe a trend in time for supply of different
nutrients and the mortality from CVD. A further aim was to compare trends
of European countries. Therefore, the mean, the minimum and the maximum
of the intake data (energy, total fat, animal fat, vegetable oil, oil crops,
carbohydrates and sugar and sweetener) were calculated for the four regions
(South, Central East, West and North) and the development was presented
in graphs.
When looking at the results, it is to keep in mind that data were received
from FBS, which calculate the food supply at the population level. Thus in-
formation for each parameter were higher than in individual based surveys.
Further, FAO received data from national statistic institutes. Data evalu-
ation as well as cultural habits differ within countries. Further reliability
and precision are questionable. Nevertheless FBS are adequate sources to
compare dietary habits among countries [Schwartz, 2003].
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Figure 3.1: Average energy supply in the four regions from 1961 to 2007.
Source of raw data: FAO, 2009
3.1.1 Energy
The mean energy supply in the South of Europe was rising from 2,671 kcal
in 1961 to 3,482 kcal/capita/day in 2007, graphically presented in figure 3.1
Italy started with the highest supply of 2,956 kcal/capita/day in 1961 which
increased to 3,646 kcal/capita/day till 2007. Cyprus represented the country
with the lowest energy supply with 2,473 kcal/capita/day in 1961 and by
3,181 kcal/capita/day in 2007.
Mean energy supply of the Central East region increased over the last
decades from 3,053 kcal/capita/day in 1961 to 3,456 kcal/capita/day in
2007. The maximum supply developed from 3,260 kcal/capita/day to 3,819
kcal/capita/day in 2007. Energy supply of Austria was the highest in 2007 in
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the Central Eastern region. Poland started with the highest energy supply,
curve rise till the eighties when it had a slight decrease. Supply is stable
since then. Romania had the lowest energy supply of 2,841 kcal/capita/day
in 1961. Since the nineties, there is a rising tendency which reached its peak
in 2006 with 2,562 kcal/capita/day. Czech Republic and Slovenia started to
collect data in 1993 (CZ) and 1992 (SL). Despite a strong increase till 2007,
they representing the countries with the lowest energy supply in the Central
East.
The progression of the West had a steady increase of the mean en-
ergy supply from 3,208 kcal/capita/day in 1961 to 3,543 kcal/capita/day
in 2007. The minimum of 3,042 kcal/capita/day in 1961 went up to 3,278
kcal/capita/day in 2007. The maximum energy supply of the West rise was
from 3,353 kcal/capita/day in 1961 to 3,694 kcal/capita/day in 2007.
While Ireland was in the maximum area in 1961 with 3,353 kcal/capita/day,
the Netherlands lay in the minimum area with 3,042 kcal/capita/day. Fur-
ther, energy supply of Belgium and Luxembourg, which was counted to-
gether back then, was the lowest in 1961 with 2,942 kcal/capita/day. This
changed over the years with a steady increase to 3,667 kcal/capita/day in
the year 2000. Hence, Belgium and Luxembourg represented with 3,694
kcal/capita/day (BE) and 3,681 kcal/capita/day (LU) as well as Ireland
(3,612 kcal/capita/day) the maximum area.
Mean energy supply in the North was 3,106 kcal/capita/day in 1961
and stayed stable until the middle of the nineties when it started to in-
crease slightly to 3,253. kcal/capita/day. In 1961, the minimum of 2,829
kcal/capita/day increased slightly to 2,962 kcal/capita/day in 2007. The
maximum had a slight rise from 3,265 kcal/capita/day in 1961 to 3,464
kcal/capita/day in 2007. Finland, Denmark, and Norway represented the
maximum area in 1961. Norway and Denmark remained in the maximum
area till 2007 with 3,464 and 3,416 kcal/capita/day.
Sweden had the minimum energy supply of 2,829 kcal/capita/day in 1961
which it runs more or less constant to 3,110 kcal/capita/day in 2007.
The Scandinavian development was stable in opposite to the Eastern Coun-
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tries of the Northern region. Estonia started with a low energy supply of 2,523
kcal/capita/day, nevertheless went up to 3,154 kcal/capita/day in 2007. Fur-
thermore, Lithuania showed an increase from 2,970 kcal/capita/day in 1992
to 3,436 kcal/capita/day in 2007 which represents nearly the maximum. On
the contrary, energy supply in Latvia decreased from 3,272 kcal/capita/d in
1992 to 2,962 kcal/capita/day in 2007 with its lowest of 2,799 kcal/capita/day
in the year 2000.
3.1.2 Fat
Total Fat
Total fat supply increased from 1961 to 2007 in all regions except the North
where supply stayed stable. From 1961 to 2007 the South had an increase
of 75.3 the West 32.4 and the Central East region 40.8 g/capita/day (Figure
3.2).
The mean of total fat supply in the South increased steadily from 73.5
g/capita/day in 1961 to 148.8 g/capita/day in 2007. The minimum ranged
from 55.7 g/capita/day in 1961 to 138.7 g/capita/day. Supply maximum
climbed from 87.2 g/capita/day in 1961 to 158.6 g/capita/day.
All countries of the South had a steady and notable increase over the last
decades. Portugal represented the minimum in 1961 with 55.8 g/capita/day
however went up to 141.3 g/capita/year. The maximum reflected by Greece
with 87.2 g/capita/day in 1961 went up to 152.0 g/capita/day in 2007. Italy
pointed out the maximum of 158.6 g/capita/day in 2007 when started with
77.2 g/capita/day in 1961.
The mean fat uptake of the Central East rose up from 93.2 g/capita/day
in 1961 to 134 g/capita/day in 2007. The gap between the minimum and the
maximum is wider compared to the South. The minimum went up from 55.8
g/capita/day in 1961 to 107.6 g/capita/day in 2007. The maximum supply
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Figure 3.2: Average fat supply in the four regions from 1961 to 2007. Source
of raw data: FAO, 2009
increased from 115 g/capita/day in 1961 to 167.9 g/capita/day in 2007.
Austria lay in the maximum area with a growth from 111.5 g/capita/day
in 1961 to 167.9 g/capita/day in 2007. The minimum was constantly repre-
sented by Romania.
The mean supply of the West evolved from 119.2 g/capita/day in 1961
to 151.6 g/capita/day in 2007. The minimum in 1961 accounted for 106.9
g/capita/day which rose to 136.6 g/capita/day in 2007. The maximum in-
creased from 136.4 g/capita/day in 1961 to 164.7 g/capita/day in 2007.
France showed the minimum supply of 106.9 g/capita/day, despite that
climbed up to 164.7 g/capita/day in 2007. Belgium and Luxembourg started
with 117 g/capita/day in 1961 and increased their fat supply to 159.3 g/capita/day
in 1999. These three countries represented the maximum area in 2007.
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In the North region, mean and maximum supply stayed about constant.
The mean went from 128.9 g/capita/day in 1961 to 119.6 g/capita/day in
2007. The maximum was at 140.5 g/capita/day in 1961 and 136.8 g/capita/day
in 2007. The minimum was constant to 1992 when fat supply dropped to
78.8 g/capita/day.
Denmark, Norway, Sweden, and Finland had a constant fat supply, thus
Norway had the maximum supply most of the past forty-seven years. Lithua-
nia, Estonia, and Latvia added the minimum supply in 1992. However, all
of them had an increase until 2007. The fat supply of Latvia increased from
94.4 g/capita/day in 1992 to 118.5 g/capita/day in 2007.
Animal Fat
The mean animal fat supply of the South had an increase of 7.4 g/capita/day
from 1961 to 2007. Animal fat supply of the Central East decreased by
6.6 g/capita/day, of the West by 9.1 g/capita/day and of the North by 25
g/capita/day.
The mean of animal fat supply in the South rose from 4.8 g/capita/day
in 1961 to 12.2 g/capita/day in 2007. The maximum had a higher increase
from 7.3 g/capita/day in 1961 to 25.8 g/capita/day in 2007. The minimum of
the animal fat supply stayed almost constant with 2.1 g/capita/day in 1961
and 4.4 g/capita/day in 2007. Italy represented the maximum in 1961 and
increased the supply up to 17.6 g/capita/day in 2007. Portugal had a animal
fat supply of 7.2 g/capita/day in 1961. It increased to the maximum of 25.8
g/capita/day in 2007. Cyprus, Spain and Greece stayed about constantly in
the minimum area.
The gap between the minimum and the maximum of the Central East
Region, was rather high in 1961. The mean decreased from 33.4 g/capita/day
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Figure 3.3: Average fat supply in the four regions from 1961 to 2007. Source
of raw data: FAO, 2009
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in 1961 to 26.8 g/capita/day in 2007. The maximum started with a supply
of 46.8 g/capita/day in 1961 and dropped to 40.4 g/capita/day in 2007. The
minimum went from 8.1 g/capita/day in 1961 to 8 g/capita/day in 2007.
While Hungary posed as the maximum in the last five decades, Romania
was the minimum. Thus they showed the same trend like the minimum
and the maximum in figure 3.3. Poland had a slight drop down from 40.3
g/capita/day in 1987 to 24.5 g/capita/day in 1994, then supply remained
stable. Animal fat supply of Austria and Germany stayed constant never-
theless high in the maximum area. Further, the minimum area is represented
by the Czech Republic and Slovenia.
In the West the mean decreased from 31.3 g/capita/day in 1961 to 22.2
g/capita/day in 2007. The minimum supply went from 21.7 g/capita/day in
1961 to 6.1 g/capita/day in 2007. The maximum, otherwise, rose from 40.6
g/capita/day in 1961 to 45.8 g/capita/day in 2007.
Belgium and Luxembourg showed the maximum until 1999. While Bel-
gium (45.5 g/capita/day) remained at the maximum level, Luxembourg (4.4
g/capita/day) remained at the minimum. In Ireland and the United King-
dom the animal fat supply decreased. France featured the only country
in the West with a slight increase from 21.7 g/capita/day in 1961 to 30.8
g/capita/day in 2007.
The mean of the North decreased from 45.8 g/capita/day in 1961 to 20.8
g/capita/day in 2007. Accordingly the maximum went from 56.7 g/capita/day
in 1961 to 46.9 g/capita/day in 2007. The minimum dropped from 30.3
g/capita/day in 1961 to 7.7 g/capita/day in 2007.
While Denmark showed the maximum supply in most of the years from 1961
to 2007, Estonia presented the minimum supply from 1992 to 2007.
Vegetable Oil
Vegetable oil trend is ascending in the South and amounts to 37,6 g/capita/day.
Iin the Central East vegetable supply increased by 29.9 g/capita/day and in
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Figure 3.4: Average vegetable oil supply in the four regions from 1961 to
2007. Source of raw data: FAO, 2009
the West by 23.1 g/capita/day. Supply of the North stayed rather stable
(Figure 3.4).
The mean of the South increased steadily from 26.6 g/capita/day in 1961
to 64.2 g/capita/day in 2007. While the maximum grew more constantly
from 47.8 g/capita/day in 1961 to 76.1 g/capita/day in 2007, the minimum
fluctuated from 25.2 g/capita/day in 1961 to 48.3 g/capita/day in 2007.
Greece represented the maximum in 1961 (47.8 g/capita/day) and further
increased the vegetable oil supply to 72 g/capita/day. Portugal represented
the minimum in 1961 and in 2007 with a constant development.
The mean of the Central East rose from 15.5 g/capita/day in 1961 to
45.4 g/capita/day in 2007. The maximum went constantly up from 28.5
g/capita/day in 1961 to 60.7 g/capita/day in 2007. The minimum increased
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steadily from 3.6 g/capita/day in 1961 to 30.9 g/capita/day in 2007. Ger-
many showed the maximum in 1961 with 28.5 g/capita/day and rose to 47.3
g/capita/day. Since 1966 Austria represented the maximum with a supply
of 60.7 g/capita/day in 2007. Hungary started as the minimum in 1961
with 3.6 g/capita/day thus increased to 54.3 g/capita/day in 2007. In 2007
Poland showed the minimum with 30.9 g/capita/day which rose from 8.9
g/capita/day in 1961.
The West developed the mean from 27.7 g/capita/day in 1961 to 50.8
g/capita/day in 2007. In 1961, minimum supply provided Ireland with 8.4
g/capita/day consequently increased to 54.3 g/capita/day in 2007. Maxi-
mum in 1961 were the Netherlands with 48.5 g/capita/day. This vegetable
oil supply was about constant the last 47 years. While Belgium with a supply
of 61.4 g/capita/day was the maximum in 2007, Luxembourg represented the
minimum by 35.8. g/capita/day.
The mean of the North developed from 24.1 g/capita/day in 1961 to
31.2 g/capita/day in 2007. Sweden was constant in the maximum area
with a supply of 42.1 g/capita/day in 2007. Supply of Lithuania, Latvia,
and Estonia was in the minimum area in 1992, however, supply of Lithua-
nia rose up to 28.1 g/capita/day in 2007. Supply of Latvia ended with 41
g/capita/day in 2007 and Estonia increased to 22.6 g/capita/day in 2007.
Denmark is the only country in the North decreasing vegetable oil supply
from 32.2 g/capita/day in 1961 to 15.8 g/capita/day in 2007.
Oil crops
The mean supply of oil crops had a slight increase in all four regions. In
the South supply went up by 1.26 g/capita/day, in the Central East 1.32
g/capita/day, in the West 1.39 g/capita/day and in the North the slightest
with 0.99 g/capita/day (Figure 3.5).
In the South Cyprus presented the maximum in all the 47 past years.
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Figure 3.5: Average oil crops supply in the four regions from 1961 to 2007.
Source of raw data: FAO, 2009
Supply fluctuated from 7.4 g/capita/day in 1961 to 8.1 g/capita/day in 2007.
Italy represented the minimum in 1961 with 0,6 g/capita/day which went to
1.2 g/capita/day in 2007. Supply of Portugal was constant, and represented
the minimum in 2007 with 1.1 g/capita/day.
In the Central East Germany with 1.1 g/capita/day had the maximum
supply which went to 2.2 g/capita/day in 2007. However, Austria’s supply
increased from 0.6 g/capita/day in 1961 to 3.7 g/capita/day in 2007 when it
reached the maximum supply. In 1961 minimum supply was represented by
Romania with 0.2 g/capita/day which rose to 1.1 g/capita/day in 2007.
Maximum of the West was represented by the United Kingdom in 1961
(1.4 g/capita/day) as well as in 2007 (3.3 g/capita/day). Ireland started with
the minimum of the West in 1961 with 0.4 g/capita/day rose since the end
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of the eighties to 1.5 g/capita/day in 2007. Belgium and Luxembourg lay
also in the minimum area, however, in 2000 Luxembourg had the minimum
supply of 1.5 g/capita/day which decreased to 0.6 g/capita/day with and
reached a peak of 2.3 g/capita/day in 2005.
Sweden demonstrated the highest supply of oil crops of the North most of
the past 47 years, thus had an increase from 1 g in 1961 to 2.4 g/capita/year
in 2007. Norway and Finland presented the minimum of 0.3 g/capita/year
in 1961 which went up to 1.4 g (Norway) and 1.6 g/capita/day (Finland)
in 2007. Estonia, the minimum, in 2007 had the slightest increase of 0.6
g/capita/day of the eastern countries of the northern region. Supply was 0.7
g/capita/day in 2007.
3.1.3 Carbohydrates
Carbohydrates supply stayed rather stable, some fluctuations were observed
but no trends (Figure 3.6). Mean supply of carbohydrates in the South went
from 420.62 g/capita/day in 1961 to 414 g/capita/day in 2007. Cyprus rep-
resented the minimum in 1961 by 366.71 and rose to 375.67 g/capita/day in
2007. Carbohydrates supply of Spain (421.13 g/capita/day, 1961) decreased
to the minimum in 2007 (351.88 g/capita/day) of the Southern region. The
highest supply in 1961 had Italy (477.01 g/capita/day) which fell to 431.36
g/capita/day in 2007. Supply of Greece increased from 419.56 g/capita/day
in 1961 to the maximum supply in 2007 ( 458.75 g/capita/day).
Germany had the lowest supply in the Central East in 1961 (374.8
g/capita/day) developing to 450.3 g/capita/day in 2007, whereas Czech Re-
public had the maximum supply of 416.4 g/capita/day in 1961. In 1961 Max-
imum was hold by Poland with 515.5 g/capita/day which slightly decreased
to 487.7 g/capita/day in 2007. Romania had a supply of 492.7 g/capita/day
in 1961 which fell till the nineties, however the supply returned to 503.68
g/capita/day in 2007, representing the maximum. The mean from 458.8
g/capita/day in 1961 to 451.6 g/capita/day in 2007 stayed stable.
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Figure 3.6: Average supply of carbohydrates in the four regions from 1961
to 2007. Source of raw data: FAO, 2009
Carbohydrate supply in the West stayed as well constant with a mean
of 417.3 g/capita/day in 1961 and 425.1 g/capita/day in 2007. Minimum
supply of 373.78 g/capita/day had Belgium and Luxembourg in 1961, later
in 2007 France with 387.17 g/capita/day. Ireland held the maximum most
of the past decades with a supply of 481.86 g/capita/day in 1961 and 472.03
g/capita/day in 2007.
The mean of the North went from 388.3 (1961) to 430.4 g/capita/day
(2007), however, supply of the countries remained stabile. Slight increase
was due to additional countries since 1993, which had a higher carbohydrate
supply. For instance Lithuania (499.7 g/captia/day, 2007) which presented
the maximum in 2007 and Latvia which dropped to the minimum in 2007
(376.69 g/capita/day).
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3.1.4 Sugar and Sweeteners
Figure 3.7: Average supply of sugar and sweeteners in the four regions from
1961 to 2007. Source of raw data: FAO, 2009
There was no trend observed of the mean of sugar and sweeteners sup-
ply for the North and the West. The South showed an increase of 38.3
g/capita/day and the Central East rose by 26,9 g/capita/day from 1961 to
2007 (Figure 3.7)
The mean of the South started with 55.9 g/capita/day in 1961 and rose
consequently to 94.2 g/capita/day with a minimum of 41.9 g/capita/day in
1961 developing to 70 g/capita/day in 2007. The maximum supply at 68.8
g/capita/day in 1961 increased to 131.5 g/capita/day
Cyprus, with a supply of sugar and sweeteners of 61.4 g/capita/day in 1961
had an increase to the maximum of 131.5 g/capita/day in 2007. Greece had
the lowest supply of 41.9 g/capita/day in 1961 which rose to 90.9 in 2007.
Greece reached the peak in 1989 with 100.8 g/capita/day. The supply of
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Spain rose from 56.2 g/capita/day in 1961 to 70.4 g/capita/day in 2007,
hence Spain represented the minimum supply in 2007.
In the Central East the mean ranged between 81.8 g/capita/day in
1961, and 108.7 g/capita/day in 2007. The maximum supply went from 112.1
g/capita/day in 1961 to 140.3 g/capita/day in 2007. While Austria, Poland,
Hungary, and Germany had an approximate stable development over the last
fourty years, the Czech Republic had a decrease from 112.9 g/capita/day in
1993 to 101.9 g/capita/day in 2007 with a peak of 150.7 g/capita/day in
2004.
Romania presented the minimum with 30.1 g/capita/day in 1961 and rose
to 78.63 g/capita/day in 2007. Slovenia reflected the minimum of 43.3
g/capita/day in 1993 and increased to 66 g/capita/day in 2007.
Countries of the West had a diverse development. The mean with
125.1 g/capita/day in 1961 and 120.1 g/capita/day in 2007 stayed con-
stant, respectively. The maximum went from 145,8 g/capita/day in 1961
to 154 g/capita/day in 2007 however maximum supply had a peak of 164.9
g/capita/day in 1991 and its lowest of 115,9 g/capita/day in 1987. The min-
imum ranged from 83.6 g/capita/day in 1961 to 99.2 g/capita/day in 2007.
Ireland represented the maximum of 145.8 g/capita/day in 1961. It reduced
the supply to 114.5 g/capita/day with the lowest of 86.6 g/capita/day in
2005. The Netherlands had a similar supply in 1961 and 2007 with 128.8
and 128.5 g/capita/day respectively, nevertheless showed the peak of 164.9
g/capita/day in 1991. United Kingdom had a decreasing trend. The supply
of sugar and sweeteners declined from 142.2 g/capita/day in 1961 to 99.1
g/capita/day in 2007. In contrast, supply in Belgium and Luxembourg in-
creased from 75.9 g/capita/day in 1961, which was the minimum at that
time, to 141.9 g/capita/day in 1999. In the year of the millennium Belgium
had a higher supply than Luxembourg. Although it decreased from 163.6
g/capita/day to 154 g/capita/day in 200, it still represented the maximum.
The mean of the North decreased from 128.9 g/capita/day in 1961 to
119.1 g/capita/day in 2007. While the minimum supply increased from 123.8
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g/capita/day in 1961 to 81.1 g/capita/day, maximum rise up from 140.8
g/capita/day in 1961 to 168.5 g/capita/day in 2007.
Denmark represented the maximum with 140.8 g/capita/day in 1961. The
supply of sugar and sweeteners went up to 168.5 g/capita/day in 2007. Fin-
land started with the highest supply of 123.8 g/capita/day in 1961. After a
irregular development it declined to 94.3 g/capita/day in 2007.
Estonia contributed with the lowest supply of 52.2 g/capita/day in 1992,
however went up to 127 g/capita/day in 2007. Latvia reduced its supply
form 110.1 g/capita/day in 1992 to 81.1 g/capita/day in 2007, and therefore
represented the minimum supply.
3.1.5 Trends of mortality from CVD
Mortality of male and female dropped from 1970 to 2009 in all four mortality
causes (mortality from diseases of the circulatory system, mortality from
ischemic diseases, mortality from cerebrovascular diseases and mortality from
all causes). In general standardised (and non standardised) death rates for
men are higher than for women in all regions and in all 4 categories. Further,
a stronger decline was observed in men than in women from 1970 to 2009
with exception of the North regarding the SDR of cerebrovascular diseases.
In that case they declined about the same amount.
The South had the lowest mean SDR for deaths caused by diseases of
the circulatory system in female in 1970 and for deaths from ischemic heart
diseases in both sexes in 1970 and 2009. In 2009, the South had the low-
est SDR for male which died of diseases of the circulatory system. Overall
mortality was the lowest in 1970 for male and in 2009 for female.
The Central East had the highest mortality rate over the years for all
causes and all years except of the mortality from ischemic diseases of men.
The North contributed the highest mortality rate in 1970 and 2009. However,
it was the region with the lowest mortality decrease of deaths from ischemic
diseases in male and female and for the SDR of cerebrovascular diseases in
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female.
The lowest SDR for deaths of the circulatory system in male in 1970
and in female in 2009 had the West. Further in 2009 for the deaths of
cerebrovascular diseases in male and female and mortality from all causes in
male. The highest decrease of the West was for the deaths of the diseases of
the circulatory system (female), of ischemic diseases (male and female), of
cerebrovascular diseases (male and female) and the mortality from all causes
(male). The lowest decline of deaths of the circulatory system in male was
also presented by the West.
The North had the lowest SDR in 1961 regarding cerebrovascular dis-
eases of male and female as well as the total mortality of female. It had
the highest SDR of ischemic diseases of male in 1970 and 2009. The lowest
decline of overall mortality and the SDR of cerebrovascular diseases in male
was provided by the North.
Mortality of diseases of the circulatory system (Figure 3.8)
In 1970 highest SDR (deaths per 100,000 inhabitants) in the South was
seen in Portugal with 416.79 in female and 599.11 in male which decreased
constantly to 152.35 in female and 208.3 in male in 2009. In 1970 Greece
showed the minimum SDR of 278.58 (female) and 326.53 (male) which went
to 219.24 (female) and 277.03 (male) in 2009, therefore represented the max-
imum in the southern area in 2009. Further, Greece had the lowest SDR in
male in comparison with all 24 countries in 1970. In 2008 Spain reached the
lowest SDR of 122.43 (female) and 183.72 (male).
Women of Romania reflected the highest SDR in the Central East over
the past 39 years as well as in comparison with all the 24 countries. There
was still a decrease from 638.89 (female) in 1970 to 461.9 in 2009. According
to men Romania was the central eastern country with the highest SDR in
2009. SDR developed from 711.19 in 1970 to 658.06 in 2009. In male,
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Figure 3.8: Standardised death rate per 100,000 inhabitants for mortality
from diseases of the circulatory system for male and female from 1970 to
2009. Source of raw data: WHO, 2010
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Hungary had the highest SDR in 1970 with 796.21 falling to 548.41 in 2009.
In 1970 the lowest SDR was observed in gave Poland for female (427.02) and
male (589.66) decreasing after a slight increase to 277.17 (female) and 463.74
(male) in 2008. SDR of Austria declined from 476.58 (for female and 684.03
for male in 1970, to the bottom of 177.23 (female) and 258.67 (male) in 2009.
In the West, Ireland had the highest SDR most of the years since 1970
when SDR was 505.93 for female and 727.6 for male. SDR dropped to 151.39
(female) and 237.85 (male) in 2009 still representing the maximum in the
West. France had the lowest SDR from 1970 to 2008, starting with 276.88
(female) and 444.05 (male) in 1970, and decreased constantly to 123.98 (fe-
male) and 193.19 (male) in 2008. Among all 25 countries France possessed
the lowest SDR for deaths of diseases of the circulatory system in female in
1961 and 2008 of all 25 countries.
Finlands SDR was the highest in the North with 554.52 (female) and
875.71 (male) in 1970. However, SDR dropped to 157.86 (female) and 294.9
(male) in 2009. Furthermore, Finland had the highest SDR in male among
all countries in 1961. In females, Lithuania demonstrated the highest SDR
in the northern region as well as in all other 25 countries in 2009. SDR
decreased from 492.12 in 1981 to 384.92 in 2009. Norway had the lowest
SDR most of the years, it dropped from 358.86 in 1970 to 124.22 in 2009.
In male Latvia had the highest SDR in 2009 which increased from 940.45 in
1980 to 671.56 in 2008. In 1970 Sweden reflected the minimum with 558.21
which fell to 245.29 in 2009. Norway’s SDR was the lowest in the northern
region and in regard to all countries. SDR fell from 581.58 in 2970 to 198.11
in 2009.
Mortality of cerebrovascular diseases (Figure 3.9)
Portugal was representing the maximum with 238.43 (female) and 292.54
(male) in 1970 for the South and for all other countries. It decreased steadily
to 66.57 in female and 84.55 in male in 2009. While in females Portugal had
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the lowest SDR of the south in 2009 whereas in male it was still the highest.
Nevertheless in 2008 Spain reflected the lowest SDR of 33.8 in female in
contrary to male where Cyprus with a SDR of 39.85 was the lowest. Greece
supplied the minimum SDR of 124.07 in 1970 in female. SDR decreased
slightly to 74.93, however presented the maximum in this area. In male
Greece represented the lowest SDR of 118.24 in 1970 which decreased to
73.64 in 2009.
The Czech Republic had the highest SDR in the Central East. It
dropped from 187.01 (female) and 229.46 (male) in 1970 to 71.62 (female)
and 88.52 (male) in 2009. Romania represented the maximum with a SDR
of 194.3 (female) and 195.3 (male) in 2009 which increased slightly form
185.73 (female) and 187.26 (male) in 1970. Overall the trend of Romania is
decreasing since the middle of the nineties. However, Romania had the high-
est SDR among all countries in 2009. The minimum SDR presented Poland
with 53.76 (female) and 57.93 (male) in 1970 for the South as well as for
all countries. Mortality slightly increased to 64.09 (female) and 91.42 (male)
in 2008. In 2009, Austria showed the minimum SDR. There was a strong
decrease observed from 160.41 to 30.23 (female) and 201.88 to 37.96 (male).
In the West, Ireland had the highest SDR in female with 159.94 falling to
38.74 till 2009. In male, the highest SDR hold Belgium with 170.83 in 1970
which fell to 47.24 in 2005. United Kingdom presented the maximum SDR
in 2009 with 41.72 (female) and 44.11 (male) falling from 143.39 (female)
and 161.3 (male). Minimum in the West showed the Netherlands in 1970
and 2009 in male as well as in female. SDR decreased from 108.86 (female)
and 116.34 (male) to 33.52 (female) and 35.93 (male). Furthermore, the
Netherlands represented the lowest SDR in male.
In 1970, the maximum SDR in the North showed Finland with 170.68
(female) and 195.31 (male) which went down to 40.33 (female) and 52.1
(male). In 2009, Lithuania had the highest SDR in the North with 105.86
in female and 138.61 in male. SDR of Lithuania stayed constant since 1981.
Sweden represented the minimum SDR in 1970. Starting with a SDR of 88
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Figure 3.9: Standardised death rate per 100,000 inhabitants for mortality
from cerebrovascular diseases for male and female from 1970 to 2009. Source
of raw data: WHO, 2010
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(female) and 95.58 (male) in 1970 it declined to 38.83 (female) and 46.96
in 2008. In 2009, Norway submitted the lowest SDR of 33.3 (female) and
43.38 (male) which decreased from 132.62 (female) and 155.87 (male) in 1970.
Norway further performed as minimum of all countries in 2009.
Mortality of ischemic diseases (Figure 3.10)
In 1970 the South had the maximum SDR represented by Italy in female and
male. SDR fell from 110.89 (female) and 189.08 (male) to 44.13 (female) and
85.55 (male) in 2007. In 2009, Greece represented the maximum SDR which
stayed constant over the past 39 years. In 2009 SDR for deaths of ischemic
diseases was 41.13 in female and 96.63 in male. Spain had the lowest SDR
in 1970 of 38.25 (female) and 77.55 (male) which decreased slightly to 29.47
(female) and 69.32 (male). In 2009 Portugal pictured the minimum SDR by
falling from 70.11 (female) and 140.63 (male) in 1971 to 30.55 (female) and
56.7 (male) in 2009. Moreover Portugal represented the smallest SDR for all
countries.
The Central East had a maximum of 226.51 (female) and 406.7 (male)
presented by Czech Republic. SDR decreased to 133.58 (female) and 218.29
(male) in 2009. Further among all countries, the Czech Republic was the
highest in 1970. Hungary had the highest SDR in 2009 with 163.04 (female)
and 288.98 (male) in 2009, but the decrease was small because of the low
initiating SDRs, 198.2 for female and 313.94 for male. In Poland SDR in-
creased from the minimum of 51.72 in female and 121.42 in male in 1970,
to 68.29 (female) and 147.53 (male) in 2008. Slovenia had the lowest SDR
in 2009. SDR went from 89.14 (female) and 185.88 (male) in 1985 to 72.56
(female) and 131.48 (male).
In women Ireland showed the maximum SDR in the West in 1970 as
well as in 2009. SDR decreased from 195.14 in 1970 to 69.2 in 2009. In
male Ireland hold the maximum SDR most of the years and had an SDR
of 143.74 in 2009 falling from 375.3 in 1979. However, in 1970, the United
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Figure 3.10: Standardised death rate per 100,000 inhabitants for mortality
from ischemic diseases for male and female from 1970 to 2009. Source of raw
data: WHO, 2010
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Kingdom had a higher SDR of 387.46 decreasing to 115.6 in 2009. SDR of
France reflected the minimum from 46.6 (female) and 106.24 (male)in 1970
to 20.31 (female) and 53.28 (male) in 2008. In 2009, minimum SDR found in
the Netherlands with 28.16 (female) and 64.64 (male) decreasing from 134.86
(female) and 294.36 (male) in 1970. While the Netherlands had the lowest
SDR in male in 2009, Spain possessed the minimum in female and male in
1961 among all countries.
While Norway had the lowest SDR in the North, declining from 135.77
(female) and 340 (male) in 1970 to 44.85 (female) and 92.35 (male) in 2009,
Sweden showed the maximum SDR in female and Finland in male in 1970.
Sweden went from 214.93 (female) in 1970 to 62.14 in 2008. Finland reduced
the SDR from 480.22 (male) in 1970 to 92.35 in 2009. However Lithuania
presented the maximum in 2009 in female and male. It decreased from 351.44
(female) and 516.07 (male) in 1985 to 229.46 (female) and 428.55 (male) in
2009.
Mortality of all causes (Figure 3.11)
The South presented the maximum by Portugal in 1970 (male and female).
SDR of total mortality declined from 1117.45 in 1970 to 470.69 in 2009 (fe-
male). In male SDR declined from 1682.88 to 790 in 2009. Additionally, in
female and in male Portugal demonstrated the maximum SDR in 1970. Por-
tugal decreased to the minimum SDR in female in 2009. In 2009 the highest
SDR in female was found in Greece with 473.26.
In 1970 and in 2009 the lowest SDR in male hold as well Greece (753.96)
which represented the minimum over all countries in male in 1970. The
greek SDR went from 1016.25 in 1970 to 693.18 in 2009.
While in the Central East Romania had the highest SDR from 1970
(1085.77) to the year 2009 (733.01) in female, in 1970 Romania presented
the minimum SDR by 1422.98 in male. Mortality stayed rather constant. In
2009 SDR was 1236.34. Furthermore Romania had the highest SDR in all
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countries in female in 1970. However in male the Czech Republic hold the
maximum SDR with 1656.24 in 1970 decreasing to 962.54 in 2009. Hungary
declined the SDR from 1970 (1513.96) to the maximum of 2009 (1244,83) In
1970 the lowest SDR in female had Poland declining from 975,32 to 588,93
in 2008. In 2009 Austria showed the minimum in female and male. In female
SDR went from 733.01 (1970) to 422.06 (2009). In male there was a stronger
decrease from 1548.2 to (1970) to 718.57 (2009).
In the West Ireland presented the highest SDR in female from 1970 to
2009. SDR dropped from 1009.24 to 476.50. Further in male Ireland hold
the highest SDR in 2009 which went from 1432,6 in 1970 to 729.79 in 2009.
In 1970 it was Belgium which had the highest SDR of 1441.37 declining to
811.42 in 2005. Netherlands showed the minimum SDR in male in 1970 and
in female in 2009. In male SDR decreased from1183.44 to 693,11 in 2009. In
female SDR went from 755.78 to 465.12 in 2009. France hold the minimum
for female in 1970 with a SDR of 743.84 going down to 385,57 in 2009. United
Kingdom had the lowest SDR in 2009 (male) developing from1411.79 in 1970
to 670.69 in 2009.
Finland had the highest SDR in the North in 1970 (female and male).
While in male SDR decreased from 1644.29 (1970) to 768,29 (2009), in female
SDR went from 966.4 (1970) to the lowest SDR of 431.92. In 2009 Lithuania
presented the maximum which stayed more stable in male than in female.
In female SDR decreased from 802.24 in 1981 to 659.24 in 2009. In male
SDR went from 1416.99 (1981) to 1416.99 (2009). Further Lithuania hold
the maximum SDR for all countries in 2009. Sweden had the lowest SDR
in both sexes in 1970 and the minimum SDR for all countries in male in
2009. In female SDR declined from 728.1 (1970) to 431.92 (2009) and in
male from 1065.45 (1970) to 642.93 (2008). In 2009 Norway represented the
minimum for the northern region with a SDR going from 1155.03 (1970) to
657.05 (2009) which additionally is the minimum for all countries in 2009.
However, examining the development of the gaps between the mean, the
minimum, and the maximum of the North and the Central East, it has been
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obvious that there was a difference in mortality from CVD in some countries.
When the gaps of the South and West heading towards each other, gaps of
the North and Central East drifted apart. Due to the fact that the division
of these regions were made in respect of the common dietary habits, there
had to be further reasons for mortality from CVD. Taking a closer look at
the countries, it appeared that EEC had a significantly higher mortality from
diseases of the circulatory system (Figure 3.12).
Figure 3.12: Mortality from diseases of the circulatory system for all countries
in 2009
3.2 Dietary Fats and Carbohydrates and Mor-
tality from CVD
Table 3.2 and Table 3.1 show the Spearman rank correlation’s rho for all
objectives as well as other risk factors (alcohol, smoking behaviour, PAL) for
women and men.
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Table 3.1: Spearman rank correlation coefficient for all objectives for malea
r P r P r P
Energy n 22 n 7 n 15
I00-99 0.1992 0.3743 -0.6071 0.1482 -0.0215 0.9394
I60-69 0.1149 0.6108 -0.6786 0.0938 -0.222 0.4264
I20-25 0.34 0.1215 -0.1429 0.7599 0.1629 0.5618
total mortality 0.3078 0.1635 -0.6786 0.0938 0.188 0.5022
CHO total n 21 n 7 n 14
I00-99 -0.0182 0.9376 -0.9643 0.0005 0.3451 0.2269
I60-69 -0.0234 0.9199 -0.9286 0.0025 0.3143 0.2738
I20-25 -0.0734 0.7519 -0.6071 0.1482 0.1648 0.5733
total mortality -0.1715 0.4573 -0.9286 0.0025 -0.0637 0.8286
Fat n 22 n 7 n 15
I00-99 0.4167 0.0537 0.75 0.0522 -0.0036 0.9899
I60-69 0.4676 0.0282 0.7143 0.0713 0.127 0.6519
I20-25 0.3042 0.1687 0.5 0.2532 -0.3292 0.2309
total mortality 0.3472 0.1134 0.7143 0.0713 -0.1932 0.4903
SFA n 18 n 5 n 13
I00-99 -0.0072 0.9773 0.5 0.391 -0.0496 0.8722
I60-69 -0.0021 0.9935 0.1 0.8729 0.0275 0.9288
I20-25 -0.215 0.3916 0.7 0.1881 -0.4821 0.0952
total mortality -0.1034 0.6832 0.1 0.8729 -0.1818 0.5522
MUFA n 15 n 4 n 11
I00-99 0.2288 0.4121 0.4 0.6 -0.1185 0.7278
I60-69 0.3253 0.2368 0.4 0.6 0.0729 0.8313
I20-25 0.1001 0.7227 -0.6 0.4 -0.3098 0.3539
total mortality 0.1573 0.5756 0.4 0.6 -0.2096 0.5363
PUFA n 15 n 4 n 11
I00-99 0.3211 0.2433 0.4 0.6 0.0966 0.7776
I60-69 0.4646 0.081 0.4 0.6 0.3724 0.2593
I20-25 -0.0646 0.8192 -0.4 0.6 -0.5702 0.067
total mortality 0.2493 0.3702 0.5 0.6 -0.0322 0.9252
Cholesterol n 17 n 6 n 11
I00-99 0.451 0.0692 0.0286 0.9572 -0.4909 0.1252
I60-69 0.4559 0.0659 -0.1429 0.7872 -0.4273 0.1899
I20-25 0.5245 0.0307 0.2 0.704 -0.2273 0.5015
total mortality 0.4926 0.0445 -0.1429 0.7872 -0.3455 0.2981
BMI n 22 n 7 n 15
I00-99 0.3265 0.138 -0.7857 0.0362 0.5627 0.029
I60-69 0.3622 0.0976 -0.75 0.0522 0.6308 0.0117
I20-25 0.253 0.256 -0.4286 0.3374 0.3369 0.2195
total mortality 0.1834 0.414 -0.75 0.0522 0.2903 0.2939
Somking n 16 n 3 n 13
I00-99 0.6814 0.0037 -0.5 0.6667 0.5695 0.0422
I60-69 0.4812 0.0591 -0.5 0.6667 0.2613 0.3884
I20-25 0.6137 0.0115 -0.5 0.6667 0.4484 0.1243
total mortality 0.6313 0.0087 -0.5 0.6667 0.4924 0.0873
Alkohol n 17 n 5 n 12
I00-99 -0.0392 0.8812 -0.2 0.7471 -0.0629 0.8549
I60-69 -0.0809 0.7576 -0.2 0.7471 -0.1259 0.6967
I20-25 0.098 0.7982 -0.3 0.6238 0.2238 0.4845
total mortality 0.2157 0.4057 -0.2 0.7471 0.4056 0.1908
PAL n 20 n 6 n 14
I00-99 0.281 0.2301 0.058 0.9131 0.0838 0.7758
I60-69 0.2719 0.2461 0.058 0.9131 -0.0419 0.8869
I20-25 0.3028 0.1944 0.116 0.8268 0.1323 0.6521
total mortality 0.116 0.6262 0.058 0.9131 -0.2823 0.3283
All Countries EEC WEC
aEEC: Czech Republic, Estonia, Hungary, Latvia, Lithuania Poland, Romania, Slove-
nia; WEC: Austria, Belgium, Denmark, Finland, France, Germany, Greece, Hungary, Ire-
land, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom; I00-99:
deaths from diseases from the circulatory system (CVD); I60-69: deaths from ischemic
heart diseases; I20-25: deaths from cerebrovascular diseases; energy (kcal/day); carbo-
hydrate intake (% of energy); fat intake (% of energy); SFA: saturated fatty acids (%
of energy); MUFA: monounsatruated fatty acids (% of energy); PUFA: polyunsaturated
fatty acids (% of energy); BMI: body mass index (kg/m2); smoking (current smokers in
% of the population, alcohol consumption in g/day); PAL: physical activity level (% of
population which never exercises)
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a EEC: Czech Republic, Estonia, Hungary, Latvia, Lithuania Poland, Ro-
mania, Slovenia; WEC: Austria, Belgium, Denmark, Finland, France, Ger-
many, Greece, Hungary, Ireland, Italy, Norway, Portugal, Spain, Sweden,
The Netherlands, United Kingdom; I00-99: deaths from diseases from the
circulatory system (CVD); I60-69: deaths from ischemic heart diseases; I20-
25: deaths from cerebrovascular diseases; energy (kcal/day); carbohydrate
intake (% of energy); fat intake (% of energy); SFA: saturated fatty acids
(% of energy); MUFA: monounsatruated fatty acids (% of energy); PUFA:
polyunsaturated fatty acids (% of energy); BMI: body mass index (kg/m2);
smoking (current smokers in % of the population, alcohol consumption in
g/day); PAL: physical activity level (% of population which never exercises)
There was no correlation observed for all countries for EEC or WEC.
Overall mortality and energy intake showed as well no link for all countries
in women and men. Further, in EEC an inverse not significant correlation
for men and was calculated.
CHO intake was in men and in women about the same, however, men
had a higher mortality rate in all four mortality causes (Figure 3.13). There
was no clear correlation, of mortality from diseases of the circulatory sys-
tem and carbohydrate intake, whereas for EEC (n 7) not significant, inverse
correlation coefficient for male and female was found.
Mortality from ischemic heart diseases had no interdependence with the
CHO intake in all European Countries, however, for EEC a strong, statis-
tically significant, inverse rank correlation of -0.9268 (P<0.05) for male was
calculated.
In all countries deaths of all causes had a high significant inverse correla-
tion of -0.9286 (P<0.05) for male. However not significant correlations have
been estimated for female.
When correlating fat intake with mortality diseases of the circulatory
system EEC (n 7) showed a relatively high correlation coefficient with 0.75
(P>0.05) for male. WEC (n 15) showed no correlation. Other causes of
52
Table 3.2: Spearman rank correlation coefficient for all objectives for femalea
r P r P r P
n 22 n 7 n 15
Energy I00-99 0.1992 0.3743 -0.6071 0.1482 -0.0215 0.9394
I60-69 0.1149 0.6108 -0.6786 0.0938 -0.222 0.4264
I20-25 0.34 0.1215 -0.1429 0.7599 0.1629 0.5618
total mortality 0.3078 0.1635 -0.6786 0.0938 0.188 0.5022
CHO total n 21 n 7 n 14
I00-99 -0.0182 0.9376 -0.9643 0.0005 0.3451 0.2269
I60-69 -0.0234 0.9199 -0.9286 0.0025 0.3143 0.2738
I20-25 -0.0734 0.7519 -0.6071 0.1482 0.1648 0.5733
total mortality -0.1715 0.4573 -0.9286 0.0025 -0.0637 0.8286
Fat n 22 n 7 n 15
I00-99 0.4167 0.0537 0.75 0.0522 -0.0036 0.9899
I60-69 0.4676 0.0282 0.7143 0.0713 0.127 0.6519
I20-25 0.3042 0.1687 0.5 0.2532 -0.3292 0.2309
total mortality 0.3472 0.1134 0.7143 0.0713 -0.1932 0.4903
SFA n 18 n 5 n 13
I00-99 -0.0072 0.9773 0.5 0.391 -0.0496 0.8722
I60-69 -0.0021 0.9935 0.1 0.8729 0.0275 0.9288
I20-25 -0.215 0.3916 0.7 0.1881 -0.4821 0.0952
total mortality -0.1034 0.6832 0.1 0.8729 -0.1818 0.5522
MUFA n 15 n 4 n 11
I00-99 0.2288 0.4121 0.4 0.6 -0.1185 0.7278
I60-69 0.3253 0.2368 0.4 0.6 0.0729 0.8313
I20-25 0.1001 0.7227 -0.6 0.4 -0.3098 0.3539
total mortality 0.1573 0.5756 0.4 0.6 -0.2096 0.5363
PUFA n 15 n 4 n 11
I00-99 0.3211 0.2433 0.4 0.6 0.0966 0.7776
I60-69 0.4646 0.081 0.4 0.6 0.3724 0.2593
I20-25 -0.0646 0.8192 -0.4 0.6 -0.5702 0.067
total mortality 0.2493 0.3702 0.5 0.6 -0.0322 0.9252
Cholesterol n 17 n 6 n 11
I00-99 0.451 0.0692 0.0286 0.9572 -0.4909 0.1252
I60-69 0.4559 0.0659 -0.1429 0.7872 -0.4273 0.1899
I20-25 0.5245 0.0307 0.2 0.704 -0.2273 0.5015
total mortality 0.4926 0.0445 -0.1429 0.7872 -0.3455 0.2981
BMI n 22 n 7 n 15
I00-99 0.3265 0.138 -0.7857 0.0362 0.5627 0.029
I60-69 0.3622 0.0976 -0.75 0.0522 0.6308 0.0117
I20-25 0.253 0.256 -0.4286 0.3374 0.3369 0.2195
total mortality 0.1834 0.414 -0.75 0.0522 0.2903 0.2939
Somking n 16 n 3 n 13
I00-99 0.6814 0.0037 -0.5 0.6667 0.5695 0.0422
I60-69 0.4812 0.0591 -0.5 0.6667 0.2613 0.3884
I20-25 0.6137 0.0115 -0.5 0.6667 0.4484 0.1243
total mortality 0.6313 0.0087 -0.5 0.6667 0.4924 0.0873
Alkohol n 17 n 5 n 12
I00-99 -0.0392 0.8812 -0.2 0.7471 -0.0629 0.8549
I60-69 -0.0809 0.7576 -0.2 0.7471 -0.1259 0.6967
I20-25 0.098 0.7982 -0.3 0.6238 0.2238 0.4845
total mortality 0.2157 0.4057 -0.2 0.7471 0.4056 0.1908
PAL n 20 n 6 n 14
I00-99 0.281 0.2301 0.058 0.9131 0.0838 0.7758
I60-69 0.2719 0.2461 0.058 0.9131 -0.0419 0.8869
I20-25 0.3028 0.1944 0.116 0.8268 0.1323 0.6521
total mortality 0.116 0.6262 0.058 0.9131 -0.2823 0.3283
All Countries EEC WEC
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deaths pictured the same scheme. Mortality of men was higher. Although
the difference in fat intake was not that much higher in men (Table 3.2).
Further, Figure 3.14 shows the correlation between saturated fatty acids
(SFA) and CVD. Spearman’s rho for correlation between mortality from
diseases of the circulatory system and SFA was for all 18 countries 0.2572
for women. For men no correlation was observed. EEC showed with 0.9
(P<0.05) for female a strong link between mortality and SFA intake. Western
European Countries seemed to have no association.
No correlation has been observed between MUFA intake and CVD mor-
tality. MUFA intake was higher for Lithuania, Poland Spain and Greece
(<14 % of Energy). Mortality in all four division was slightly higher in men,
nevertheless with the same correlation pattern (Figure 3.14)
PUFA intake was below the recommended 10 % of energy in all european
countries. The difference in mortality rates of Hungary in male and female led
to a not significant inverse correlation coefficient in EEC in all four mortality
divisions (Table 3.2).
Risk factors for CVD (BMI, smoking behaviour, alcohol consumption,
PAL) showed a link with mortality rates for male (Figure 3.15). Interestingly,
a higher BMI correlates with higher mortality of diseases of the circulatory
system in WEC in men (r= 0.5627, P<0.05; n 15). In contrast, in EEC an
inverse correlation was estimated in men (r= -0.7857, P<0.05; n 7) and no
correlation for female population existed.
For correlation of the BMI with mortality from ischemic heart diseases, a
Spearman’s rho of 0.4969 (P<0.05) was estimated. In WEC a stronger cor-
relation for male (r= 0.6308; P<0.05) was detected (Table 3.1).
Smoking behaviour of all observed countries was linked to mortality from
CVD in male (r= 0.6814, P<0.05; n 16). In WEC a correlation coefficient of
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0.5696 (P<0.05; n13) was estimated for male (Table 3.1.
For alcohol consumption no correlation was observed in male for all coun-
tries and WEC.
Correlating all countries PAL, when comparing with CVD mortality, for
EEC and WEC no correlation was observed. All correlations are shown
graphically in Figure 3.14 and Figure 3.15.
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Figure 3.13: Correlation between mortality of diseases of the circulatory sys-
tem (SDR per 100.000 inhabitants) and Energy intake (MJ) in male and
female. EEC: Czech Republic, Estonia, Hungary, Latvia, Lithuania Poland,
Romania, Slovenia; WEC: Austria, Belgium, Denmark, Finland, France, Ger-
many, Greece, Hungary, Ireland, Italy, Norway, Portugal, Spain, Sweden, The
Netherlands, United Kingdom. Source of raw data: European Health and
Nutrition Report 2009; WHO, 2010
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Figure 3.14: Correlation between mortality of diseases of the circulatory
system (SDR per 100.000 inhabitants) and SFA intake (% of energy) MUFA
(% of energy) and PUFA (% of energy) in male and female. Source of raw
data: European Health and Nutrition Report 2009; WHO, 2010
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Figure 3.15: Correlation between risk factors and mortality of diseases from
the circulatory system. BMI (kg/m2), smoking behaviour (% of current
smokers in a population), alcohol consumption (g/day) in male and female.
Source of raw data: European Health and Nutrition Report 2009; WHO,
2010
Chapter 4
Discussion
There has been observed a decreasing trend in mortality from CVD in all
four regions. Mortality rates for male declined more than for female. This
could have been explained with the gender ratio. Data from WHO was for
the whole population of the country, which means that 100,000 inhabitants
were male and female counted together. In most industrialised countries this
ratio was 65:100 (female:male), due to differences between life expectation
[WHO, 1995]. However, this did not implicate that CVD was no problem
in the worlds population. Better medical health systems and interventions
could have prevented CVD deaths. Nevertheless, with respect to the death
causes, the CVD trend was rising [WHO, 2011a].
Men showed a higher consumption of alcohol. Furthermore, more men
tended to be smokers. These risk factors could have lead to a higher mortality
of CVD in male than in female. In this examination, no link between mortal-
ity from CVD and alcohol consumption was found for men. For women, a non
significant inverse correlation between mortality from diseases of the circula-
tory system and alcohol consumption was estimated. Correlation coefficient
was significant for mortality from ischemic diseases and alcohol consump-
tion (r= -0.4877, P<0.05; n17). In EEC, correlation coefficients were even
higher, although the number of objectives was low and the estimates were
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not significant. Alcohol intake could have had protective effects in lower
dose, otherwise excessive alcohol consumption had unfavourable effects on
cardiovascular health [Baua et al., 2007]. Intake of female, with exception
of danish women, was below the recommendations. Consequently the es-
timates were conform to the literature. Alcohol consumption of male was
slightly over the recommended amount, however, there was no correlation in
respect to cardiovascular mortality in Western European Countries for men
and women.
Examining the development of the gaps between the mean, the minimum,
and the maximum of the North and the Central East, it has been obvious
that there was a difference in mortality from CVD in some countries. When
the gaps of the South and West heading towards each other, gaps of the
North and Central East drifted apart. Due to the fact that the division of
these regions were made in respect of the common dietary habits, there had
to be further reasons for mortality from CVD. Taking a closer look at the
countries, it appeared that EEC had a significantly higher mortality from
diseases of the circulatory system (Figure 3.12).
This was a result of differences in medical treatments and individually tar-
geted interventions. Furthermore, disparity between social and economic risk
factors might have been a reason for higher mortality from CVD in eastern
european countries [Chow et al., 2009]. For instance, the price of cigarettes
rose in most developed countries, while in contrast they were affordable eas-
ier in developing countries [Guindon et al., 2002]. Examining the smoking
habits of eastern european countries, the proportion of current smokers as
percentage of the population was not higher than WEC, even lower. Esti-
mated Spearman’s rho for mortality from diseases of the circulatory system
and smoking of men for 16 countries over europe was significant with 0.6814
(P<0.05). For cerebrovascular diseases, calculated spearmans rho of 0.6137
(P<0.05; n= 16) for men was similar. The not significant correlation for
mortality of ischemic diseases was slightly lower. In EEC, no correlation was
found. Smoking habits of men in WEC correlated with the CVD mortal-
ity (r= 0.5695, P<0.05; n= 15). These were quite strong correlations and
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consistent with the literature that smoking is an independent risk factor for
CVD [Bazzano et al., 2003].
Another independent risk factor was the BMI. Mean was beyond the rec-
ommendations for a population by every country with exception of females
of Austria and Poland [Elmadfa, 2009]. Non significant correlations between
mortality from diseases of the circulatory system and BMI for men and for
women were estimated. BMI of men from EEC correlated inversely with the
mortality from CVD (r= -0.7857, P<0.05; n= 7). Social and economic rea-
sons might have been responsible for this [Chow et al., 2009]. It is likely that
people which had a purchasing power in EEC had a higher BMI [Ulijanszek
and Koziel, 2007], hence, could have had access to better medical treatment
in EEC.
The trend of energy supply in Europe showed a clear rising tendency, with
exception of the North (dietary devision), which only had a slightly rising
trend. It needs to be asked what the nutrient is that was consumed by the
population. When the nutrition habits would have been equal to those 47
years ago, the trend in all commodities would have risen equal the increase
of energy.
In the South, energy supply had the strongest increase in the past decades.
While mean total fat supply rose, mean carbohydrate supply decreased slightly
in the South. In the Northern region, a rising trend in energy supply was
observed as well as in the western region. Although the increase was stronger
in the North than in the West. However, both had a constant mean carbo-
hydrate supply and a rising tendency in mean total fat supply. The North
showed the slightest rising mean energy supply. While the mean fat sup-
ply remained constant, mean carbohydrate supply rose slightly in the North
since the nineties. Further, the North had the strongest decline in animal
fat, however the south had a lower animal fat supply in 2007. Furthermore,
the North had the slightest increase in vegetable oil.
Finland, for instance, had the highest international decline in coronary heart
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diseases since 1960. After 1977 national preventive activities were conducted
[Puska et al., 1983]. Due to Vartiainen et al. the 80 % decline in coronary
mortality in Finland was achieved through a great reduction of the metabolic
risk factor levels [Vartiainen et al., 2010]. The observed trends of nutrient
intake of the North pointed out the findings of Vartiainen et al.
Further, calculations in this study estimated a link of mortality from
CVD and energy intake. For women of the EEC, a not significant inverse
correlation between energy intake and mortality from ischemic diseases was
found. This could have also been a result of socioeconomical differences. In
most of the EEC, economic inequality rose after the collapse of communism
[Rosser et al., 2000]. Therefore, people with a high purchasing power could
afford a high energy intake, and further a better medical treatment.
However, a positive caloric balance leads to obesity [Bays, 2011] which is an
independent risk factor for CVD [Poirier et al., 2006]. Further, a BMI over
30 kg/m2 is a risk factor for Type II Diabetes Mellitus, high blood pressure
and dyslipidemia which indirectly increases CVD risks well [Bays, 2009].
Considering the trend of energy intake which was rising especially in the
South and the West, it was obvious that BMI was increasing as well.
An important finding were the correlation coefficients between carbohy-
drate intake and CVD mortality, and between fat intake and CVD mortality.
In EEC, an inverse correlation was observed for male between carbohydrate
intake and total CVD mortality (r= -0.9643, P<0.05; n= 7), and mortality
from ischemic diseases (r= -0.9286, P<0.05). Further, in women of the EEC,
correlation was inverse, however, no significance was given. This could have
been due to the differences of independent risk factors such as smoking or
alcohol. In this study these risk factors were not implemented. More men
tended to be smokers or drinking more alcohol which lead to a higher mor-
tality from CVD [Baua et al., 2007]. Therefore, CVD mortality of men was
higher than of women.
In men, a not significant correlation between fat intake and CVD mortal-
ity was observed within all countries. In EEC, the correlation was even
stronger, nevertheless not significant. However, in WEC no correlation was
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found, which could have been due to the differences in the medical treatment
[Chow et al., 2009].
The study of Berglund et al. estimated changes in metabolic risk factors.
Exchanging fat of the diet with carbohydrates lowers LDL and HDL but
rises TG levels [Berglund et al., 2007].
The amount of kcal per gram carbohydrate was about the half of the kcal per
gram fat. Hence, caloric balance might have been more likely to be achieved
in order to avoid obesity. The strong, not significant correlation between
total fat intake and mortality from CVD for male and female was supporting
this thought, on the basis of the fact that obesity an independent risk factor
for CVD mortality [Poirier et al., 2006].
However, the importance of the quality of fat was beyond controversy,
when thinking about the functions such as being part of membranes. Satu-
rated fatty acids were not linked with cardiovascular mortality in male (all
countries). In EEC, a strong significant correlation was found in women (r=
0.9, P<0.05). In the meta-analysis of Siri-Tariano et al., who evaluated epi-
demiological studies, saturated fatty acids were not significantly linked to a
higher CVD risk [Siri-Tarino et al., 2010]. However in metabolic studies sat-
urated fatty acids had a cholesterol rising effect [Kris-Etherton and Yu, 1997]
which increased the CVD risk [NCEP, 2002]. Most of the estimated corre-
lations were not significant regarding SFA, however there was a correlation
between CVD mortality and SFA intake in EEC.
No correlation between MUFA and CVD mortality was observed. Au-
thors of prior ecological studies emphasised a rather high correlation between
MUFA and SFA intakes and specified SFA as a confounding variable compro-
mising conclusions, when linking MUFA with risk of CHD [Gillingham et al.,
2011]. Further studies regarding an exchange of SFA with MUFA advocated
a higher MUFA intake, however, these studies observed risk factors such as
plasma cholesterol to estimate the CHD risk [Cao et al., 2009].
In all European countries a not significant correlation between PUFA in-
take and mortality from ischemic diseases was observed for male. Contrarily,
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in WEC an inverse not significant correlation was observed between mor-
tality from cerebrovascular diseases and PUFA intake. All countries stayed
below the reference value (6-11% of energy), some even lower [Elmadfa, 2009].
However, estimates of EEC resulted in no significance, due to a small number
of observations. Countries of EEC could have confounded the estimates for
all european countries. Nevertheless the inverse relationship of the PUFA
intake and mortality from cerebrovascular diseases agreed with the findings
of Mozzafarin et al., that a higher PUFA intake could have decreased the
risk of mortality from CVD [Mozaffarian et al., 2010].
In EEC, it seemed nutrient uptake was correlating higher with mortal-
ity than in WEC. On the contrary, in WEC independent risk factors gave
the impression to be rather linked to CVD mortality. CVD is a multifacto-
rial disease. The various risk factors (dietary and individual) changed the
metabolic risk factors, such as plasma cholesterol and hypertension. Medi-
cal treatment would have been able to change these risk factors by medical
interventions, which differed between WEC and EEC. The objective of this
study, though, was mortality from CVD, not the incidents. Furthermore, it
is suspected that the inverse relationship, between CVD mortality and the
BMI in EEC indicates the possibility of a link between purchasing power for
food and further, for medical treatment in EEC. Further energy intake of
EEC correlated, although not significant with the CVD mortality in EEC.
Nevertheless, independent risk factors correlated, with exception of al-
cohol consumption and physical activity level, with CVD mortality in male
within all countries. Therefore, these risk factors should be taken into ac-
count in further ecological studies to estimate the impact of total fat uptake
and the quality of fat on mortality from CVD.
A caveat of this study was the small number of countries. Only some cor-
relations had a P value lower than 0.05. Further, the questionable reliance
on the accuracy of the dietary assessments of the nutrient assessment needed
to be kept in mind. Underreporting of food intake was likely. Regarding
the high prevalence of overweight and obesity in european countries, most
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adults did not meet the recommended balance of energy intake and energy
requirement, especially when considering the low physical activity in all euro-
pean countries [Elmadfa, 2009]. Nevertheless, the collected data are a useful
source to compare the countries and to estimate correlations to indicate the
risk of CVD.
However, this study showed that excessive energy intake, hence obesity,
had unfavourable influences on CVD mortality. Reducing energy intake with
replacement of fat with carbohydrates had a positive impact on obesity preva-
lence, thus, a cardiovascular protective effect. Regarding the fat quality there
was no clear indication, that it would have been favourable to replace SFA
with PUFA, when energy intake was not over requirement.
Bibliography
http://www.who.int/mediacentre/factsheets/fs317/en/index.html Date ac-
cessed: 27/6/2011.
World Health Statistics 2009. http://www.who.int/whosis/whostat/EN
WHS09 Full.pdf.
Anitschkow N. A history of experimentation on arterial atherosclerosis in
animals. Springfield IL, Charles C. Thomas, 1967.
Ascherio A, Rimm EB, Giovannucci EL, Spiegelman D, Stampfer
M, and Willet WC. Dietary fat and risk of coronary heart disease
in men: cohort follow up study ind the United States. Brithish Medical
Journal, 1996, 313: 84–90.
Baua Paulo, Bauc Claiton, Rositod Guido A., Manfroie Wal-
domiro C., and Fuchs Fla´vio D. Alcohol consumption, cardiovascu-
lar health, and endothelial function markers Alcohol consumption, cardio-
vascular health, and endothelial function markers Alcohol consumption,
cardiovascular health, and endothelial function markers. Alkohol, 2007,
41(7): 479–488.
Bays Harold E. Adiposopathy is ”sick fat” a cardiovascular disease? J
Am Coll Cardiol, Jun 2011, 57(25): 2461–73.
Bays HE. ”Sick fat”, metabolic disease and atherosclerosis. American
Journal of Medicine, 2009, 122: 26–37.
66
Bays HE, and Ballantyne C. Adiposopathy: sich fat causes high blood
pressure and dyslipidemia. Future Lipidology, 2006, 1: 389–420.
Bazzano Lydia A., He Jiang, Muntner Paul, Vupputuri Suma,
and Whelton Paul K. Relationship between Cigarette Smoking and
Novel Risk Factors for Cardiovascular Disease in the United States. Annals
of Internal Medicine, 2003, 138(11): 891–898.
Berglund Lars, Lefevre Michael, Ginsberg Henry N, Kris-
Etherton Penny M, Elmer Patricia J, Stewart Paul W, Er-
show Abby, Pearson Thomas A, Dennis Barbara H, Roheim
Paul S, Ramakrishnan Rajasekhar, Reed Roberta, Stewart
Kent, and Phillips Kathrine M. Comparison of monounsaturated
fat with carbohydrates as a replacement for saturated fat in subjects with
a high metabolic risk profile: studies in the fasting and postprandial states.
American journal of clinical nutrition, 2007, 86: 1611–20.
Berry E, Eisenberg S, Friedlander Y, and et al. Effects of diets
rich in monounsaturated fatty acids on plasma lipoproteins - the Jerusalem
Murtition Study. II. Monounsaturated fatty acids vx carbohydrates. Amer-
ican journal of clinical nutrition, 1992, 56: 394–403.
Boehmer TK, Lovegreen SL, Haire-Joshu D, and Brownson RC.
What constitutes an obesogenic environment in rural communities. Amer-
ican Journal of Health Promotion, 2006, 20: 411–421.
Cao Y, Mauger David T., Pelkman Christine L., Zhao Guixiang,
Townsend Stacie M., and Kris-Etherton Penny M. Effects of
moderate (MF) versus lower fat (LF) diets on lipids and lipoproteins: a
meta-analysis of clinical trials in subjects with and without diabetes. Jour-
nal of Clinical Lipidology, 2009, 3(1): 19–32.
Chow Clara Kayei, Lock Karen, Teo Koon, Subramanian SV,
McKee Martin, and Yusuf Salim. Environmental and societal influ-
ences acting on cardiovascular risk factors and disease at a population level:
a review. International Journal of Epidemiology, 2009, 38: 1580–1594.
67
Cummins S, and Macintyre S. Food environments and obesity-
neighbourhood or nation. International Journal of Epidemiology, 2006,
35: 100–104.
EFSA. 2010 (March). Scientific Opinion on Dietary Reference Values for
fats, including saturated fatty acids, polyunsaturated fatty acids, monoun-
saturated fatty acids, trans fatty acids, and cholesterol.
Elmadfa Ibrahim. European Nutrition and Health Report 2009. Karger,
2009.
Elmadfa Ibrahim, and Leitzmann Claus. Erna¨hrung des Menschen.
Vol. 4. UTB, 2004.
EUROCISS. European cardiovascular surveillance set. European Journal
of Cardiovascular Prevention and Rehabilitation, Dec 2007, 14 (Suppl.
3)(Dec).
FAO. 2008 . Food Balance Sheets - A Handbook. FAO, Rome.
Gillingham Leah G, Harris-Janz Sydney, and Jones Peter J H.
Dietary monounsaturated fatty acids are protective against metabolic syn-
drome and cardiovascular disease risk factors. Lipids, Mar 2011, 46(3):
209–28.
Gillman MW, Cupples LA, Millen BE, Ellison RC, and Wolf
PA. Inverse association of dietary fat with development of ischemic stroke
in men. Journal of the American Medical Association, 1997, 278: 1245–50.
Graham I, Atar D, Borch-Johnson K, Boysen G, Burell G,
Cifkova R, Dallongeville J, DeBacker G, Ebrahim S, Gjelsvik
B, Herrmann-Lingen C, Hoes A, Humphries S, napton M, Perk
J, Priori SG, Pyorala K, Reiner Z, Ruilope L, Sans-Menendez
S, Scholteop Reimer W, Weissberg P, Wood D, Yarnell J, and
Zamorano JL. European guidelines on cardiovascular disease prevention
in clinical practice: executive summary. European Heart Journal, 2007,
28: 1275–2414.
68
Guindon GE, Tobin S, and Yach D. Trends and affordability of cigarette
prices: ample room for tax increases and related health gains. Tobacco
Control, 2002, 11: 35–43.
Haffner S M, Stern M P, Hazuda H P, Mitchel B D, and Patter-
son J K. Cardiovascular risk factors in confirmed prediabetic individuals.
Does the clock for coronary heart disease start ticking before the onset of
clinical diabetes. Journal of the American Medical Association, 1990, 268:
2893–2898.
Hamazaki T, and Okuyama H. The Japan Society for Lipid Nutrition
recommends to reduce the intake of linoleic acid. A review and critique of
the scientific evidence. World Rev Nutr Diet, 2003, 109–132.
Haskell WL, Lee I, Pate RR, Powell KE, Blair SN, Franklin
BA, Macera CA, Heath GW, Thompson PD, and Bauman A.
Physical activity and public health: updated recommendation for adults
from the American College of Sports Medicine and the American Heart
Association. Medicine and Science in Sports and Exercise, 2007, 39: 1423–
1434.
Hegsted DM, and Ausman LM. Diet, alcohol and coronary heart disease
in men. Journal of Nutrition, 1988, 118(10): 1184–1189.
Hengsted DM, McGandy RB, Myers ML, and Stare FJ. Quanti-
tative effects of dietary fat on serum cholesterol in man. American journal
of clinical nutrition, 1965, 17: 281–295.
Higuchi ML, Gutierrez PS, Bezerra HG, and et al. Comparison
between adventitial and intimal inflammation of ruptured and nonruptured
atherosclerotic plaques in human coronary arteries. Arquivos Brasileiros
de Cardiologia, 2002, 79: 20–24.
Howell WH, McNamara DJ, Tosca MA, Smith BT, and Gaines
JA. Plasma lipid and lipoprotein responses to dietary fat and cholesterol:
a meta analysis. American journal of clinical nutrition, 1997, 65: 1747–
1764.
69
Hu FB, Stampfer MJ, Manson JE, Colditz GA, Speizer FE, Hen-
nekens CH, and Willet WC. Dietary fat intake and risk of coronary
heart disease in women. New England Journal of Medicine, 1997, 227:
1491–1499.
Hu FB, Willett WC, Li T, Stampfer MJ, Colditz GA, and Man-
son JE. Adiposity as compared with physical activity in predicting mor-
tality among women. New England Journal of Medicine, 2004, 351: 2694–
2703.
Hu Frank B., Manson JoAnn E., and Willett Walter C. Types
of Dietary Fat and Risk of Coronary Heart Disease: A Critical Review.
Journal of the American College of Nutrition, 2001, 20(1): 5–19.
Judd Joseph T, Clevidence Beverly A, Muesing Richard A,
Wittes Janet, Sunkin Matthew E, and Podczasy John J. Di-
etary trans fatty acids: effects on plasma lipids and lipoproteins of healthy
men and women. American journal of clinical nutrition, 1994, 59: 861–
868.
Kato H, Tillotson J, Nichaman MZ, Rhoads GG, and Hamil-
ton HB. Epidemiologic studies of coronary heart disease and stroke in
Japanese men living in Japan, Hawaii and California. American journal
of epidemiology, 1973, 79: 372–385.
Keys A. Seven Countries: A Multivariante Analysis of Death and Coronary
Heart Disease. Cambridge, MA: Harvard University Press, 1980.
Keys A, and et al. The diet and 15-year death rate in the seven countries
study. American journal of epidemiology, 1986, 124(6): 903–915.
Kris-Etherton P, and Yu S. Individual fatty acids on plasma lipids and
lipoproteins: human studies. American journal of clinical nutrition, 1997,
65(Suppl): 1628S–1644S.
Kris-Etherton Penny, Fleming Jennifer, and Harris William.
The Debate about n-6 Polyunsaturated Fatty Acid Recommendations for
70
Cardiovascular Health. Journal of the American Dietetic Association,
February 2010, 110(2): 201–204.
Kris-Etherton PM. AHA Science Advisory. Monounsaturated fatty acids
and risk of cardiovascular disease. Circulation, 1990, 100(11): 1253–1258.
Lewington S, Whitlock G, Clarke R, Sherliker P, and Ember-
son J. Blood cholesterol and vascular mortality by age, sex, and blood
pressure: a meta-analysis of individual data from 61 prospective studies
with 55.000 vascular deaths. The Lancet, 2007, 370(9602): 1829 – 1839.
Liu J, Fox CS, Hickson D, and et al. Pericardial adipose tissue,
atherosclerosis , and cardiovascular disease risk factors: the Jackson Heart
Study. Diabetes Care, 2010, 33: 1635–9.
Menotti A, Blackbun H, and et al. Comparison of multivariate pre-
dictive power of major risk factors for coronary heart diseases in different
countries: results from eight nations of the Seven Countries Study. Journal
of Cardiovasc Risk, 1996, 3: 69–75.
Physical Activity and Reduced Risk of Cardiovascular Events: Potential Me-
diating Mechanismus. http://circahajournals.org/content/116/19/2110
Date accessed: 25.11.2011.
Moreno JJ, and Mitjavila MT. A degree of unsaturation of dietary
fatty acids and the development of atherosclerosis. Journal of Nutrition
and Biochemistry, 2003, 14(4): 182–195.
Morland K, Diez-Roux AV, and Wing S. Supermakets, other food
stores, and obesity: the atherosclerosis risk in communities study. Ameri-
can Journal of Preventive Medicine, 2006, 30: 333–39.
Mozaffarian Dariush, Micha Renata, and Wallace Sarah. Effects
on Coronary Heart Disease of Increasing Polyunsaturated Fat in Place of
Saturated Fat: A Systematic Review and Meta-Analysis of Randomized
Controlled Trials. PLoS Med, 03 2010, 7(3): e1000252.
71
Muscat JE, Harris RE, Haley NJ, and Wynder EL. Cigarette smok-
ing and plasma cholesterol. American Heart Journal, 1991, 121: 141–147.
NCEP. Third report of the National Cholesterol Education Program (NCEP)
Expert Panel on Detection, Evaluation, and Treatment of High Blood
Cholesterol in Adults (Adult Treatment Panel III): Final Repor. NIH Pub-
lication 02-5215. US Department of Health and Human Services; Public
Health Service; National Institutes of Health; National Heart, Lung, and
Blood Institute. 2002 (September).
Cardiovascular Diseases in Europe, Euro Heart Survey 2006.
http://www.escardio.org/guidelines-surveys/ehs/Pages/all-
publications.aspx.
Panico S., and Mattiello A. Epidemiology of cardiovascular diseases
in women in Europe. Nutrition, Metabolism and Cardiovascular Diseases,
2010, 20(6): 379–385.
Pischon T, an GS Hotamisligil SE Hankinson, Rifai N, and WC
WC Willett. Habitual dietary intake of n-3 and n-6 fatty acids in
relation to inflammatory markers among US men and women. Circulation,
2003, 155–160.
Poirier P, Giles TD, Bray GA, and et al. Obesity and cardiovascular
disease: pathophysiology, evaluation and effect of weight loss: an update of
the 1997 American Heart Association Scientific Statement on Obesity and
Heart Disease from the Obesity Committee of the Council on Nutrition,
Physical Activity and Metabolism. Circulation, 2006, 113: 898–918.
Puska P, Salonen JT, Nissinen A, Tuomilehto J, Vartiainen E,
and et al. H Korhonen. Change in risk factors for coronary heart
disease during 10 years of a community intervention programme (North
Karelia project. British Medical Journal, 1983, 287: 1840–1844.
Rani M, Bonu S, Jha P, Nguyen SN, and Jamjoum L. Tobacco use
in India: prevalence and predictors of smoking and chewing in a national
cross sectional household survey. Tobacco Control, 2003, 12: e4.
72
Rorrey BB, Kinsella K, and Taeuber CM. An aging world. US
Bureau of teh Census, International Population Reports, 1987, 95.
Rosser J, Rossner MV, and Ahmed E. Income inequality and the infor-
mal economy in transition economies. Journal of eomparative economics,
2000, 28: 156–171.
Saelens BE, Sallis JF, Black JB, and Chen D. Neighborhoodbased
differences in physical activity; an environment scale evaluation. American
Journal of Public Health, 2003, 93: 1552–28.
Schwartz Friedrich W. Das Public Health Buch. Urban Fischer, 2003.
Shils Maurice E, Olson James A, and Shike Moshe. Modern nutri-
tion in health and disease. 8th edn. Vol. 2. Williams & Wilkins, 1994.
Siri-Tarino Patty W, Sun Qi, Hu Frank B, and Krauss Ronald M.
Meta-analysis of prospective cohort studies evaluating the association of
saturated fat with cardiovascular disease. Am J Clin Nutr, Mar 2010,
91(3): 535–46.
Stamler J, Dyer AR, Shekelle RB, Neaton JD, and Stamler R.
Relationship of baseline major risk factors to coronary and all-cause mor-
tality, and to longevity: findings from long-term follow-up of Chicago co-
horts. Cardiology, 1993, 82: 191–222.
Summers LK, Fielding BA, Bradshaw HA, Ilic V, and Beysen
C. Substituting dietary saturated fat with polyunsaturated fat changes
abdominal fat distribution and improves insulin sensitivity. Diabetologia,
2002, 45: 369–377.
Tchoukalova YD, Koutsari C, Votruba SB, and et al. Sex- and
depot-dependet differences in adipogenesis in normal-weight humans. Obe-
sity (Silver Spring), 2010, 18: 1875–80.
Ulijanszek Stanley J., and Koziel Slawomir. Nutrition transition
and dietary energy availability in Eastern Europe after the collapse of
commusnism. Economics & Human Biology, 2007, 5(3): 359–369.
73
Vartiainen Erkki, Laatikainen Tiina, Peltonen Markku, Juolevi
Anne, Ma¨nnisto¨ Satu, Sundvall Jouko, Jousilahti Pekka, Sa-
lomaa Veikko, Valsta Liisa, and Puska Pekka. Thirty-five-year
trends in cardiovascular risk factors in Finland. International Journal of
Epidemiology, 2010, 39: 504–518.
Watsen Ronald R. Nutrition and heart Disease. Vol. 2. Boca Raton,
Florida: CRC Press, Inc, 2000.
WHO. Epidemiology and prevention of cardiovascular diseases in elderly
people. WHO Technical Report Series 853. World Health Organization,
Geneva. 1995 .
WHO. 2008 . Indicator definitions and metadata.
WHO. 2011b (November).
(WHO) World Health Organization, Food, and (FAO) Agricul-
ture Organization. Diet, Nutrition and Prevention of Chronic Dis-
eases. Report of a Joint WHO/FAO Expert Consultation. World Health
Organisation Technical Report Series, 2003, 916(i-vii): 1–149.
Abstract
The science of nutrition is discussing whether it is more beneficial for the
cardiovascular health to replace fat with carbohydrates, or replace saturated
fatty acids with fats of higher quality. Metabolic studies showed that CVD
risk factors such as hypertension and blood lipids can be influenced posi-
tively when exchanging saturated fatty acids with monounsaturated fatty
acids, polyunsaturated fatty acids or carbohydrates. However, excessive en-
ergy intake is a further risk factor for CVD. The trend of the nutrient intake
was observed in four regions of Europe, which were classified according to
dietary habits of each country.
The main part of this study estimated the extent to which dietary nutrient
intake, such as fat and carbohydrates, and the different fatty acids correlate
with CVD mortality in 25 european countries. Further, correlations of inde-
pendent risk factors, such as smoking, alcohol consumption, and BMI were
estimated.
After comparing the mortality from CVD with fat and carbohydrate in-
take there is a coherence between fat intake and CVD mortality. Further, the
carbohydrate intake correlated inversely with the CVD mortality. Neverthe-
less, no clear indication for the mortality risk from CVD and the fat quality
could be made. However, the increasing trend in energy intake is leading to
the conclusion of this study, that exchanging fat with carbohydrates could
decrease the energy intake and therefore the CVD risk factor obesity.
Zusammenfassung
In der Erna¨hrungswissenschaft wird diskutiert, ob es fu¨r die kardiovaskula¨re
Gesundheit vorteilhafter ist, dia¨tetisches Fett durch Kohlehydrate, oder gesa¨ttigte
Fettsa¨uren durch qualitativ hochwertigere Fettsa¨uren zu ersetzen.
Aus metabolischen Studien geht hervor, dass Risikofaktoren fu¨r kardio-
vaskula¨re Erkrankungen, wie Hypertonie und schlechte Blutfettwerte, pos-
itiv beeinflusst werden ko¨nnen, indem gesa¨ttigte Fettsa¨uren durch einfach
ungesa¨ttigte, mehrfach ungesa¨ttigten Fettsa¨uren, oder aber auch mit Saccha-
riden in der Dia¨t ersetzt werden. Eine u¨berma¨§ige Energieaufnahme zeigte
ebenso eine Beeinflussung der Risikofaktoren. Der Trend fu¨r die Na¨hrstoffaufnahme
und die Mortalita¨t wurde fu¨r vier la¨nderu¨bergreifenden Regionen in Europa
ermittelt. Die La¨nder, die den Regionen zugeteilt wurden, glichen sich in
ihren Erna¨hrungsgewohnheiten. Es wurde der Zusammenhang zwischen der
Aufnahme von Fett und Kohlehydraten, mit der Mortalita¨t, die durch Herz-
Kreislauf-Erkrankungen hervorgerufen wurde, in 25 europa¨ischen La¨ndern er-
mittelt. Des weiteren wurden Korrelationen zwischen unabha¨ngigen Risiko-
faktoren, wie Rauchen, Alkoholkonsum und BMI und der Mortalita¨t von
Herz-Kreislauf-Erkrankungen erhalten.
Es stellte sich eine positive Korrelation zwischen der Fettaufnahme, und
eine inverse Korrelation zwischen der Kohlehydrataufnahme und der Mor-
talita¨t heraus. Jedoch konnte keine eindeutige Erkenntnis u¨ber das Mor-
talita¨tsrisiko in Bezug auf die Fettqualita¨t gewonnen werden. Nichts desto
trotz ko¨nnte eine Senkung der Energieaufnahme durch den Austausch von
iii
Fetten durch Kohlehydrate das U¨bergewicht und in weiterer Folge das Herzkreis-
lauferkrankungsrisiko senken.
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